GLYPHOSATE TOLERANT 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASES

Abstract: Genes encoding class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share very little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted crop field.

Description: GLYPHOSATE TOLERANT 5-ENOLPYR-_V_^,SHIKIMATE-3-PHOSPHATE SYNTHASES This is a continuation-in-part of a copending U.S. patent application having serial number 07/576,537, filed August 31 , 1990 and entitled "Glyphosate Tolerant 5-Enolpyruvylshikimate-3-Phosphate Synthases." BACKGROUND OF THE INVENTION This invention relates in general to plant molecular biology and, more particularly, to a new class of glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases. Recent advances in genetic engineering have provided the requisite tools to transform plants to contain foreign genes. It is now possible to produce plants which have unique characteristics of agronomic importance. Certainly, one such advantageous trait is more cost effective, environmentally compatible weed control via herbicide tolerance. Herbicide-tolerant plants may reduce the need for tillage to control weeds thereby effectively reducing soil erosion. One herbicide which is the subject of much investigation in this regard is N-phosphonomethylglycine commonly referred to as glyphosate. Glyphosate inhibits the shikimic acid pathway which leads to the biosynthesis of aromatic compounds including amino acids, plant hormones and vitamins. Specifically, glyphosate curbs the conversion of phosphoenolpyruvic acid (PEP) and 3-phosphoshikimic acid to 5-enolpyτuvyl-3-phosphoshikimic acid by inhibiting the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (hereinafter referred to as EPSP synthase or EPSPS). It has been shown that glyphosate tolerant plants can be produced by inserting into the genome of the plant the capacity to produce a higher level of EPSP synthase in the chloroplast of the cell (Shah et al., 1986) which enzyme is preferably glyphosate tolerant (Kishore et al. 1988). Variants of the wild-type EPSPS enzyme have been isolated which are glyphosate tolerant as a result of alterations in the EPSPS amino acid coding sequence (Kishore and Shah, 1988; Schulz et al., 1984; Sost et al., 1984; Kishore et al., 1986). These variants typically have a higher Ki for glyphosate than the wild-type EPSPS enzyme which confers the glyphosate tolerant phenotype, but these variants are also characterized by a high K m for PEP which makes the enzyme kinetically less efficient (Kishore and Shah, 1988; Sost et al., 1984; Schulz et al., 1984; Kishore et al., 1986); Sost and Amrhein, 1990). For example, the apparent K m for PEP and the apparent Kj for glyphosate for the native EPSPS from E. coli are 10 μM and 0.5 μM while for a glyphosate tolerant isolate having a single amino acid substitution of an alanine for the glycine at position 96 these values are 220 μM and 4.0 mM, respectively. A number of glyphosate tolerant plant variant EPSPS genes have been constructed by mutagenesis. Again, the glyphosate tolerant EPSPS was impaired due to an increase in the K m for PEP and a slight reduction of the V max of the native plant enzyme (Kishore and Shah, 1988) thereby lowering the catalytic efficiency (Vm a x Km) of the enzyme. Since the kinetic constants of the variant enzymes are impaired with respect to PEP, it has been proposed that high levels of overproduction of the variant enzyme, 40-80 fold, would be required to maintain normal catalytic activity in plants in the presence of glyphosate (Kishore et al., 1988). While such variant EPSP synthases have proved useful in obtaining transgenic plants tolerant to glyphosate, it would be increasingly beneficial to obtain an EPSP synthase that is highly glyphosate tolerant while still kinetically efficient such that the amount of the glyphosate tolerant EPSPS needed to be produced to maintain normal catalytic activity in the plant is reduced or that improved tolerance be obtained with the same expression level. Previous studies have shown that EPSPS enzymes from different sources vary widely with respect to their degree of sensitivity to inhibition by glyphosate. A study of plant and bacterial EPSPS enzyme activity as a function of glyphosate concentration showed that there was a very wide range in the degree of sensitivity to glyphosate. The degree of sensitivity showed no correlation with any genus or species tested (Schulz et al., 1985). Insensitivity to glyphosate inhibition of the activity of the EPSPS from the Pseudomonas sp. PG2982 has also been reported but with no details of the studies (Fitzgibbon, 1988). In general, while such natural tolerance has been reported, there is no report suggesting the kinetic superiority of the naturally occurring bacterial glyphosate tolerant EPSPS enzymes over those of mutated EPSPS enzymes nor have any of the genes been characterized. Similarly, there are no reports on the expression of naturally glyphosate tolerant EPSPS enzymes in plants to confer glyphosate tolerance. SUMMARY OF THE INVENTION A DNA molecule comprising DNA encoding a kinetically efficient, glyphosate tolerant EPSP synthase is presented. The EPSP synthases of the present invention reduce the amount of overproduction of the EPSPS enzyme in a transgenic plant necessary for the enzyme to maintain catalytic activity while still conferring glyphosate tolerance. This and other EPSP synthases described herein represent a new class of EPSPS enzymes, referred to hereinafter as Class II EPSPS enzymes. Class II EPSPS enzymes share little homology to known bacterial or plant EPSPS enzymes and exhibit tolerance to glyphosate while maintaining suitable K m (PEP) ranges. Suitable ranges of K m (PEP) for EPSPS for enzymes of the present invention are between 1- 150 μM, with a more preferred range of between 1-35 μM, and a most preferred range between 2-25 μM. These kinetic constants are determined under the assay conditions specified hereinafter. The V ma x of the enzyme should preferably be at least 15% of the uninhibited plant enzyme and more preferably greater than 25%. An EPSPS of the present invention preferably has a Ki for glyphosate range of between 25-10000 μM. The Kj/K m ratio should be between 3-500, and more preferably between 6-250. The V max should preferably be in the range of 2-100 units/mg (μmoles/minute.mg at 25°C) and the K m for shikimate-3-phosphate should preferably be in the range of 0.1 to 50 μM. Genes coding for Class II EPSPS enzymes have been isolated from three (3) different bacteria: Agrobacterium tumefaciens sp. strain CP4, Achromobacter sp. strain LBAA, and Pseudomonas sp. strain PG2982. The LBAA and PG2982 Class II EPSPS genes have been determined to be identical and the proteins encoded by these two genes are very similar to the CP4 protein and share approximately 84% amino acid identity with it. Class II EPSPS enzymes can be readily distinguished from Class I EPSPS's by their inability to react with polyclonal antibodies prepared from Class I EPSPS enzymes under conditions where other Class I EPSPS enzymes would readily react with the Class I antibodies. Other Class II EPSPS enzymes can be readily isolated and identified by utilizing a nucleic acid probe from one of the Class II EPSPS genes disclosed herein using standard hybridization techniques. Such a probe from the CP4 strain has been prepared and utilized to isolate the Class II EPSPS genes from strains LBAA and PG2982. These genes may also be adapted for enhanced expression in plants by known methodology. Such a probe has also been used to identify homologous genes in bacteria isolated de noυo from soil. The Class II EPSPS enzymes are preferably fused to a chloroplast transit peptide (CTP) to target the protein to the chloroplasts of the plant into which it may be introduced. Chimeric genes encoding this CTP-Class II EPSPS fusion protein may be prepared with an appropriate promoter and 3' polyadenylation site for introduction into a desired plant by standard methods. Therefore, in one aspect, the present invention provides a new class of EPSP synthases that exhibit a low K m for phosphoenolpyruvate (PEP), a high V max K m ratio, and a high Kj for glyphosate such that when introduced into a plant, the plant is made glyphosate tolerant such that the catalytic activity of the enzyme and plant metabolism are maintained in a substantially normal state. For purposes of this discussion, a highly efficient EPSPS refers to its efficiency in the presence of glyphosate. In another aspect of the present invention, a double- stranded DNA molecule comprising DNA encoding a Class II EPSPS enzyme is disclosed. A Class II EPSPS enzyme DNA sequence is disclosed from three sources: Agrobacterium sp. strain designated CP4, Achromobacter sp. strain LBAA and Pseudomonas sp. strain PG2982. In a further aspect of the present invention, a nucleic acid probe from an EPSPS Class II gene is presented that is suitable for use in screening for Class II EPSPS genes in other sources by assaying for the ability of a DNA sequence from the other source to hybridize to the probe. In yet another aspect of the present invention, transgenic plants and transformed plant cells are disclosed that are made glyphosate tolerant by the introduction of a Class II EPSPS gene into the plant's genome. In a still further aspect of the invention, a recombinant, double-stranded DNA molecule comprising in sequence: a) a promoter which functions in plant cells to cause the production of an RNA sequence; b) a structural DNA sequence that causes the production of an RNA sequence which encodes a Class II EPSPS enzyme; and c) a 3' nontranslated region which functions in plant cells to cause the addition of a stretch of polyadenyl nucleotides to the 3' end of the RNA sequence where the promoter is heterologous with respect to the structural DNA sequence and adapted to cause sufficient expression of the fusion polypeptide to enhance the glyphosate tolerance of a plant cell transformed with said DNA molecule. In still another aspect of the present invention, a method for selectively controlling weeds in a crop field is presented by planting crop seeds or crop plants transformed with a Class II EPSPS gene to confer glyphosate tolerance to the plants which allows for glyphosate containing herbicides to be applied to the crop to selectively kill the glyphosate sensitive weeds, but not the crops. Other and further objects, advantages and aspects of the invention will become apparent from the accompanying drawing figures and the description of the invention. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows the DNA sequence (SEQ ID NO:l) for the full-length promoter of figwort mosaic virus (FMV35S). Figure 2 shows the cosmid cloning vector pMON17020. Figure 3 shows the structural DNA sequence (SEQ ID NO:2) for the Class II EPSPS gene from bacterial isolate Agrobacterium sp. strain CP4 and the deduced amino acid sequence (SEQ ID NO:3). Figure 4 shows the structural DNA sequence (SEQ ID NO:4) for the Class II EPSPS gene from the bacterial isolate Achromobacter sp. strain LBAA and the deduced amino acid sequence (SEQ ID NO:5). Figure 5 shows the structural DNA sequence (SEQ ID NO:6) for the Class II EPSPS gene from the bacterial isolate Pseudomonas sp. strain PG2982 and the deduced amino acid sequence (SEQ ID NO:7). Figure 6 shows the Bestfit comparison of the E. coli EPSPS amino acid sequence (SEQ ID NO:8) with that for the CP4 EPSPS (SEQ ID NO:3). Figure 7 shows the Bestfit comparison of the CP4 EPSPS amino acid sequence (SEQ ID NO:3) with that for the LBAA EPSPS (SEQ ID NO:5). Figure 8 shows the structural DNA sequence (SEQ ID NO:9) for the synthetic CP4 Class II EPSPS gene. Figure 9 shows the DNA sequence (SEQ ID NO: 10) of the chloroplast transit peptide (CTP) and encoded amino acid sequence (SEQ ID NO:ll) derived from the Arabidopsis thaliana EPSPS CTP and containing a Sphl restriction site at the chloroplast processing site, hereinafter referred to as CTP2. Figure 10 shows the DNA sequence (SEQ ID NO: 12) of the chloroplast transit peptide and encoded amino acid sequence (SEQ ID NO:13) derived from the Arabidopsis thaliana EPSPS gene and containing an .EcoRI restriction site within the mature region of the EPSPS, hereinafter referred to as CTP3. Figure 11 shows the DNA sequence (SEQ ID NO:14) of the chloroplast transit peptide and encoded amino acid sequence (SEQ ID NO:15) derived from the Petunia hybrida EPSPS CTP and containing a Sphl restriction site at the chloroplast processing site and in which the amino acids at the processing site are changed to -Cys-Met-, hereinafter referred to as CTP4. Figure 12 shows the DNA sequence (SEQ ID NO: 16) of the chloroplast transit peptide and encoded amino acid sequence (SEQ ID NO: 17) derived from the Petunia hybrida EPSPS gene with the naturally occurring EcoRI site in the mature region of the EPSPS gene, hereinafter referred to as CTP5. Figure 13 shows a plasmid map of CP4 plant transformation/ expression vector pMON17110. Figure 14 shows a plasmid map of CP4 synthetic EPSPS gene plant transformation/expression vector pMON17131. Figure 15 shows a plasmid map of CP4 EPSPS free DNA plant transformation expression vector pMON 13640. Figure 16 shows a plasmid map of CP4 plant transformation/direct selection vector pMON17227. Figure 17 shows a plasmid map of CP4 plant transformation/expression vector pMON19653. STATEMENT OF THE INVENTION The expression of a plant gene which exists in double-stranded DNA form involves synthesis of messenger RNA (mRNA) from one strand of the DNA by RNA polymerase enzyme, and the subsequent processing of the mRNA primary transcript inside the nucleus. This processing involves a 3' non-translated region which adds polyadenylate nucleotides to the 3' end of the RNA. Transcription of DNA into mRNA is regulated by a region of DNA usually referred to as the "promoter." The promoter region contains a sequence of bases that signals RNA polymerase to associate with the DNA, and to initiate the transcription into mRNA using one of the DNA strands as a template to make a corresponding complementary strand of RNA. A number of promoters which are active in plant cells have been described in the literature. These include the nopaline synthase (NOS) and octopine synthase (OCS) promoters (which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens), the cauliflower mosaic virus (CaMV) 19S and 35S promoters, the light-inducible promoter from the small subunit of ribulose bis-phosphate carboxylase (ssRUBISCO, a very abundant plant polypeptide) and the full-length transcript promoter from the figwort mosaic virus (FMV35S). All of these promoters have been used to create various types of DNA constructs which have been expressed in plants; see, e.g., PCT publication WO 84/02913 (Rogers et al., Monsanto). Promoters which are known or are found to cause transcription of DNA in plant cells can be used in the present invention. Such promoters may be obtained from a variety of sources such as plants and plant DNA viruses and include, but are not limited to, the CaMV35S and FMV35S promoters and promoters isolated from plant genes such as ssRUBISCO genes. As described below, it is preferred that the particular promoter selected should be capable of causing sufficient expression to result in the production of an effective amount of a Class II EPSPS to render the plant substantially tolerant to glyphosate herbicides. The amount of Class II EPSPS needed to induce the desired tolerance may vary with the plant species. It is preferred that the promoters utilized have relatively high expression in all meristematic tissues in addition to other tissues inasmuch as it is now known that glyphosate is translocated and accumulated in this type of plant tissue. Alternatively, a combination of chimeric genes can be used to cumulatively result in the necessary overall expression level of the selected Class II EPSPS enzyme to result in the glyphosate tolerant phenotype. The mRNA produced by a DNA construct of the present invention also contains a 5 * non-translated leader sequence. This sequence can be derived from the promoter selected to express the gene, and can be specifically modified so as to increase translation of the mRNA. The 5' non-translated regions can also be obtained from viral RNAs, from suitable eukaryotic genes, or from a synthetic gene sequence. The present invention is not limited to constructs, as presented in the following examples, wherein the non-translated region is derived from both the 5' non-translated sequence that accompanies the promoter sequence and part of the 5' non-translated region of the virus coat protein gene. Rather, the non-translated leader sequence can be derived from an unrelated promoter or coding sequence as discussed above. A preferred promoter for use in the present invention is the full-length transcript (SEQ ID NO:l) promoter from the figwort mosaic virus (FMV35S) which functions as a strong and uniform promoter with particularly good expression in meristematic tissue for chimeric genes inserted into plants, particularly dicotyledons. The resulting transgenic plant in general expresses the protein encoded by the inserted gene at a higher and more uniform level throughout the tissues and cells of the transformed plant than the same gene driven by an enhanced CaMV35S promoter. Referring to Figure 1, the DNA sequence (SEQ ID NO:l) of the FMV35S promoter is located between nucleotides 6368 and 6930 of the FMV genome. A 5' non-translated leader sequence is preferably coupled with the promoter. The leader sequence can be from the FMV35S genome itself or can be from a source other than FMV35S. The 3' non-translated region of the chimeric plant gene contains a polyadenylation signal which functions in plants to cause the addition of polyadenylate nucleotides to the 3' end of the viral RNA. Examples of suitable 3' regions are (1) the 3' transcribed, non-translated ' regions containing the polyadenylated signal of Agrobacterium tumor-inducing (Ti) plasmid genes, such as the nopaline synthase (NOS) gene, and (2) plant genes like the soybean storage protein genes and the small subunit of the ribulose-l,5-bisphosphate carboxylase (ssRUBISCO) gene. An example of a preferred 3' region is that from the ssRUBISCO gene from pea (E9), described in greater detail below. The DNA constructs of the present invention also contain a structural coding sequence in double-stranded DNA form which encodes a glyphosate tolerant, highly efficient Class II EPSPS enzyme. Identification of glyphosate tolerant, highly efficient EPSPS enzvmes In an attempt to identify and isolate glyphosate tolerant, highly efficient EPSPS enzymes, kinetic analysis of the EPSPS enzymes from a number of bacteria exhibiting tolerance to glyphosate or that had been isolated from suitable sources was undertaken. It was discovered that in some cases the EPSPS enzymes showed no tolerance to inhibition by glyphosate and it was concluded that the tolerance phenotype of the bacterium was due to an impermeability to glyphosate or other factors. In a number of cases, however, microorganisms were identified whose EPSPS enzyme showed a greater degree of tolerance to inhibition by glyphosate and that displayed a low K m for PEP when compared to that previously reported for other microbial and plant sources. The EPSPS enzymes from these microorganisms were then subjected to further study and analysis. Table I displays the data obtained for the EPSPS enzymes identified and isolated as a result of the above described analysis. Table I includes data for three identified Class II EPSPS enzymes that were observed to have a high tolerance to inhibition to glyphosate and a low K for PEP as well as data for the native Petunia EPSPS and a glyphosate tolerant variant of the Petunia EPSPS referred to as GA101. The GA101 variant is so named because it exhibits the substitution of an alanine residue for a glycine residue at position 101 (with respect to Petunia) in the invariant region. When the change introduced into the Petunia EPSPS (GA101) was introduced into a number of other EPSPS enzymes, similar changes in kinetics were observed, an elevation of the IQ for glyphosate and of the K m for PEP. Tahle l Kinetic rharafterization of EPSPS enzvmes ENZYME SOURCE Petunia Petunia GA101 PG2982 LBAA CP4 i Range of PEP tested = 1-40 μM 2 Range of PEP tested = 5-80 μM 3 Range of PEP tested = 1.5-40 μM The Agrobacterium sp. strain CP4 was initially identified by its ability to grow on glyphosate as a carbon source (10 mM) in the presence of 1 mM phosphate. The strain CP4 was identified from a collection obtained from a fixed-bed immobilized cell column that employed Mannville R-635 diatomaceous earth beads. The column had been run for three months on a waste-water feed from a glyphosate production plant. The column contained 50 mg/ml glyphosate and NH 3 as NH 4 CI. Total organic carbon was 300 mg/ml and BOD's (Biological Oxygen Demand - a measure of "soft" carbon availability) were less than 30 mg/ml. This treatment column has been described (Heitkamp et al., 1990). Dworkin-Foster minimal salts medium containing glyphosate at 10 mM and with phosphate at 1 mM was used to select for microbes from a wash of this column that were capable of growing on glyphosate as sole carbon source. Dworkin-Foster minimal medium was made up by combining in 1 liter (with autoclaved H 2 0), 1 ml each of A, B and C and 10 ml of D (as per below) and thiamine HC1 (5 mg). A . D-F Salts (1000X stock; per 100 ml; autoclaved): H3BO3 1 mg MnS0 4 .7H 2 0 1 mg ZnS0 4 .7H 2 0 12.5 mg CuS0 4 .5H 2 0 8 mg NaMo0 3 .3H 2 0 1.7 mg B. FeSO 4 .7H 2 0 (1000X stock; per 100 ml; autoclaved) 0.1 g C . MgS0 .7H 2 0 (1000X stock; per 100 ml; autoclaved) 20 g D. (NH ) 2 S0 (100X stock; per 100 ml; autoclaved) 20 g Yeast Extract (YE; Difco) was added to a final concentration of 0.01 or 0.001%. The strain CP4 was also grown on media composed of D-F salts, amended as described above, containing glucose, gluconate and citrate (each at 0.1 %) as carbon sources and with inorganic phosphate (0.2 - 1.0 mM) as the phosphorous source. Other Class II EPSPS containing microorganisms were identified as Achromobacter sp. strain LBAA, which was from a collection of bacteria previously described (Hallas et al., 1988), and Pseudomonas sp. strain PG2982 which has been described in the literature (Moore et al. 1983; Fitzgibbon 1988). It had been reported previously, from measurements in crude lysates, that the EPSPS enzyme from strain PG2982 was less sensitive to inhibition to glyphosate than that of E. coli, but there has been no report of the details of this lack of sensitivity and there has been no report on the K m for PEP for this enzyme or of the DNA sequence for the gene for this enzyme (Fitzgibbon, 1988; Fitzgibbon and Braymer, 1990). Relationship of the Class II EPSPS to those previously studied All EPSPS proteins studied to date have shown a remarkable degree of homology. For example, bacterial and plant EPSPS's are about 54% identical and with similarity as high as 80%. Within bacterial EPSPS's and plant EPSPS's themselves the degree of identity and similarity is much greater (see Table II). 1 The EPSPS sequences compared here were obtained from the following references: E. coli, Rogers et al., 1983; S. typhimurium, Stalker et al., 1985; Petunia hybrida, Shah et al., 1986; and Tomato, Gasser et al., 1988. When crude extracts of CP4 and LBAA bacteria (50 μg protein) were probed using rabbit anti-EPSPS antibody (Padgette et al. 1987) to the Petunia EPSPS protein in a Western analysis, no positive signal could be detected, even with extended exposure times (Protein A - 1251 development system) and under conditions where the control EPSPS (Petunia EPSPS, 20 ng; a Class I EPSPS) was readily detected. The presence of EPSPS activity in these extracts was confirmed by enzyme assay. This surprising result, indicating a lack of similarity between the EPSPS's from these bacterial isolates and those previously studied, coupled with the combination of a low K m for PEP and a high Kj for glyphosate, illustrates that these new EPSPS enzymes are different from known EPSPS enzymes (now referred to as Class I EPSPS). Glyphosate Tolerant Enzvmes in Microbial Isolates For clarity and brevity of disclosure, the following description of the isolation of genes encoding Class II EPSPS enzymes is directed to the isolation of such a gene from a bacterial isolate. Those skilled in the art will recognize that the same or similar strategy can be utilized to isolate such genes from other microbial isolates, plant or fungal sources. Cloning of the Aerobacterium sp. strain CP4 EPSPS Gene(s) in E, coli Having established the existence of a suitable EPSPS in Agrobacterium sp. strain CP4, two parallel approaches were undertaken to clone the gene: cloning based on the expected phenotype for a glyphosate tolerant EPSPS; and purification of the enzyme to provide material to raise antibodies and to obtain amino acid sequences from the protein to facilitate the verification of clones. Cloning and genetic techniques, unless otherwise indicated, are generally those described in Maniatis et al., 1982 or Sambrook et al., 1987. The cloning strategy was as follows: introduction of a cosmid bank of strain Agrobacterium sp. strain CP4 into E. coli and selection for the EPSPS gene by selection for growth on inhibitory concentrations of glyphosate. Chromosomal DNA was prepared from strain Agrobacterium sp. strain CP4 as follows: The cell pellet from a 200 ml L-Broth (Miller, 1972), late log phase culture of Agrobacterium sp. strain CP4 was resuspended in 10 ml of Solution I; 50 mM Glucose, 10 mM EDTA, 25 mM Tris -CL pH 8.0 (Birnboim and Doly, 1979). SDS was added to a final concentration of 1% and the suspension was subjected to three freeze-thaw cycles, each consisting of immersion in dry ice for 15 minutes and in water at 70°C for 10 minutes. The lysate was then extracted four times with equal volumes of phenol:chloroform (1:1; phenol saturated with TE; TE = 10 mM Tris pH8.0; 1.0 mM EDTA) and the phases separated by centrifugation (15000g; 10 minutes). The ethanol-precipitable material was pelleted from the supernatant by brief centrifugation (8000g; 5 minutes) following addition of two volumes of ethanol. The pellet was resuspended in 5 ml TE and dialyzed for 16 hours at 4°C against 2 liters TE. This preparation yielded a 5 ml DNA solution of 552 μg/ml. Partially-restricted DNA was prepared as follows. Three 100 μg aliquot samples of CP4 DNA were treated for 1 hour at 37°C with restriction endonuclease Hindlll at rates of 4, 2 and 1 enzyme unit/μg DNA, respectively. The DNA samples were - pooled, made 0.25 mM with EDTA and extracted with an equal volume of pheno chloroform. Following the addition of sodium acetate and ethanol, the DNA was precipitated with two volumes of ethanol and pelleted by centrifugation (12000 g; 10 minutes). The dried DNA pellet was resuspended in 500 μl TE and layered on a 10-40% Sucrose gradient (in 5% increments of 5.5 ml each) in 0.5 M NaCl, 50 mM Tris pH8.0, 5 mM EDTA. Following centrifugation for 20 hours at 26,000 rpm in a SW28 rotor, the tubes were punctured and -1.5 ml fractions collected. Samples (20 μl) of each second fraction were run on 0.7% agarose gel and the size of the DNA determined by comparison with linearized lambda DNA and iϊ dIII-digested lambda DNA standards. Fractions containing DNA of 25-35 kb fragments were pooled, desalted on AMICON10 columns (7000 rpm; 20°C; 45 minutes) and concentrated by precipitation. This procedure yielded 15 μg of CP4 DNA of the required size. A cosmid bank was constructed using the vector pMON17020. This vector, a map of which is presented in Figure 2, is based on the pBR327 replicon and contains the spectinomycin/streptomycin (Sp r ;spc) resistance gene from Tn7 (Fling et al., 1985), the chloramphenicol resistance gene (Cmr;c<_- ) from Tτι9 (Alton et al., 1979), the genelO promoter region from phage T7 (Dunn et al., 1983), and the 1.6 kb Bglll phage lambda cos fragment from pHC79 (Hohn and Collins, 1980). A number of cloning sites are located downstream of the cat gene. Since the predominant block to the expression of genes from other microbial sources in E. coli appears to be at the level of transcription, the use of the T7 promoter and supplying the T7 polymerase in trans from the pGPl-2 plasmid (Tabor and Richardson, 1985), enables the expression of large DNA segments of foreign DNA, even those containing RNA polymerase transcription termination sequences. The expression of the spc gene is impaired by transcription from the T7 promoter such that only Cmr ca n be selected in strains containing pGPl-2. The use of antibiotic resistances such as Cm resistance which do not employ a membrane component is preferred due to the observation that high level expression of resistance genes that involve a membrane component, i.e. β-lactamase and Amp resistance, give rise to a glyphosate tolerant phenotype. Presumably, this is due to the exclusion of glyphosate from the cell by the membrane localized resistance protein. It is also preferred that the selectable marker be oriented in the same direction as the T7 promoter. The vector was then cut with Hindlll and treated with calf alkaline phosphatase (CAP) in preparation for cloning. Vector and target sequences were ligated by combining the following: Vector DNA (HinάllVCAP) 3 μg Size fractionated CP4 Hindlll fragments 1.5 μg 10X ligation buffer 2.2 μl T4 DNA ligase (New England Biolabs) (400 U/μl) 1.0 μl and adding H 0 to 22.0 μl. This mixture was incubated for 18 hours at 16°C. 10X ligation buffer is 250 mM Tris-HCl, pH 8.0; 100 mM MgCl 2 ; 100 mM Dithiothreitol; 2 mM Spermidine. The ligated DNA (5 μl) was packaged into lambda phage particles (Stratagene; Gigapack Gold) using the manufacturer's procedure. A sample (200 μl) of E. coli HB101 (Boyer and Rolland-Dussoix, 1973) containing the T7 polymerase expression plasmid pGPl-2 (Tabor and Richardson, 1985) and grown overnight in L-Broth (with maltose at 0.2% and kanamycin at 50 μg/ml) was infected with 50 μl of the packaged DNA. Transformants were selected at 30°C on M9 (Miller, 1972) agar containing kanamycin (50 μg/ml), chloramphenicol (25 μg/ml), L-proline (50 μg/ml), L-leucine (50 μg/ml) and Bl (5 μg/ml), and with glyphosate at 3.0 mM. Aliquot samples were also plated on the same media lacking glyphosate to titer the packaged cosmids. Cosmid transformants were isolated on this latter medium at a rate of -5 x 105 per μg CP4 iϊ dlll DNA after 3 days at 30°C. Colonies arose on the glyphosate agar from day 3 until day 15 with a final rate of -1 per 200 cosmids. DNA was prepared from 14 glyphosate tolerant clones and, following verification of this 5 phenotype, was transformed into E. coli GB100/pGPl-2 (E. coli GB100 is an aroA derivative of MM294 [Talmadge and Gilbert, 1980]) and tested for complementation for growth in the absence of added aromatic amino acids and aminobenzoic acids. Other aroA strains such as SR481 (Bachman et al. 1980; Padgette et al., 1987), 10 could be used and would be suitable for this experiment. The use of GB100 is merely exemplary and should not be viewed in a limiting sense. This aroA strain usually requires that growth media be supplemented with L-phenylalanine, L-tyrosine and L-tryptophan each at 100 μg/ml and with para-hydroxybenzoic 15 acid, 2,3-dihydroxybenzoic acid and para-aminobenzoic acid each at 5 μg/ml for growth in minimal media. Of the fourteen cosmids tested only one showed complementation of the aroA- phenotype. Transformants of this cosmid, pMON17076, showed weak but uniform growth on the unsupplemented minimal media after 10 20 days. The proteins encoded by the cosmids were determined in vivo using a T7 expression system (Tabor and Richardson, 1985). Cultures of E. coli containing pGPl-2 (Tabor and Richardson, 1985) and test and control cosmids were grown at 25 30°C in L-broth (2 ml) with chloramphenicol and kanamycin (25 and 50 μg/ml, respectively) to a Klett reading of - 50. An aliquot was removed and the cells collected by centrifugation, washed with M9 salts (Miller, 1972) and resuspended in 1 ml M9 medium containing glucose at 0.2%, thiamine at 20 μg/ml and containing 30 the 18 amino acids at 0.01% (minus cysteine and methionine). Following incubation at 30°C for 90 minutes, the cultures were transferred to a 42°C water bath and held there for 15 minutes. Rifampicin (Sigma) was added to 200 μg/ml and the cultures held at 42°C for 10 additional minutes and then transferred to 30°C for 20 minutes. Samples were pulsed with 10 μCi of 35S-methionine for 5 minutes at 30°C. The cells were collected by centrifugation and suspended in 60-120 μl cracking buffer (60 mM Tris-HCl 6.8, 1% SDS, 1% 2-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue). Aliquot samples were electrophoresed on 12.5% SDS-PAGE and following soaking for 60 minutes in 10 volumes of Acetic Acid-Methanol-water (10:30:60), the gel was soaked in ENLIGHTNING ™ (DUPONT) following manufacturer's directions, dried, and exposed at -70°C to X-Ray film. Proteins of about 45 kd in size, labeled with 35S-methionine, were detected in number of the cosmids, including pMON17076. Purification of EPSPS from Aεrobacterium SP. strain CP4 All protein purification procedures were carried out at 3-5°C. EPSPS enzyme assays were performed using either the phosphate release or radioactive HPLC method, as previously described in Padgette et al. 1987, using 1 mM phosphoenol pyruvate (PEP, Boehringer) and 2 mM shikimate-3-phosphate (S3P) substrate concentrations. For radioactive HPLC assays, 14C-PEP (Amersham) was utilized. S3P was synthesized as previously described in Wibbenmeyer et al. 1988. N-terminal amino acid sequencing was performed by loading samples onto a Polybrene precycled filter in aliquots while drying. Automated Edman degradation chemistry was used to determine the N-terminal protein sequence, using an Applied Biosytems Model 470A gas phase sequencer (Hunkapiller et al. 1983) with an Applied Biosystems 120A PTH analyzer. Five 10-litre fermentations were carried out on a spontaneous "smooth" isolate of strain CP4 that displayed less clumping when grown in liquid culture. This reduced clumping and smooth colony morphology may be due to reduced polysaccharide production by this isolate. In the following section dealing with the purification of the EPSPS enzyme, CP4 refers to the "smooth" isolate - CP4-S1. The cells from the three batches showing the highest specific activities were pooled. Cell paste of Agrobacterium sp. CP4 (300 g) was washed twice with 0.5 L of 0.9% saline and collected by centrifugation (30 minutes, 8000 rpm in a GS3 Sorvall rotor). The cell pellet was suspended in 0.9 L extraction buffer (100 mM TrisCl, 1 mM EDTA, 1 mM BAM (Benzamidine), 5 mM DTT, 10% glycerol, pH 7.5) and lysed by 2 passes through a Manton Gaulin cell. The resulting solution was centrifuged (30 minutes, 8000 rpm) and the supernatant was treated with 0.21 L of 1.5% protamine sulfate (in 100 mM TrisCl, pH 7.5, 0.2% w/v final protamine sulfate concentration). After stirring for 1 hour, the mixture was centrifuged (50 minutes, 8000 rpm) and the resulting supernatant treated with solid ammonium sulfate to 40% saturation and stirred for 1 hour. After centrifugation (50 minutes, 8000 rpm), the resulting supernatant was treated with solid ammonium sulfate to 70% saturation, stirred for 50 minutes, and the insoluble protein was collected by centrifugation (1 hour, 8000 rpm). This 40-70% ammonium sulfate fraction was then dissolved in extraction buffer to give a final volume of 0.2 L, and dialyzed twice (Spectrum 10,000 MW cutoff dialysis tubing) against 2 L of extraction buffer for a total of 12 hours. To the resulting dialyzed 40-70% ammonium sulfate fraction (0.29 L) was added solid ammonium sulfate to give a final concentration of 1 M. This material was loaded (2 ml/min) onto a column (5 cm x 15 cm, 295 ml) packed with phenyl Sepharose CL-4B (Pharmacia) resin equilibrated with extraction buffer containing 1 M ammonium sulfate, and washed with the same buffer (1.5 L, 2 ml/min). EPSPS was eluted with a linear gradient of extraction buffer going from 1 M to 0.00 M ammonium sulfate (total volume of 1.5 L, 2 ml/min). Fractions were collected (20 ml) and assayed for EPSPS activity by the phosphate release assay. The fractions with the highest EPSPS activity (fractions 36-50) were pooled and dialyzed against 3 x 2 L (18 hours) of 10 mM TrisCl, 25 mM KCl, 1 mM EDTA, 5 mM DTT, 10% glycerol, pH 7.8. The dialyzed EPSPS extract (350 ml) was loaded (5 ml/min) onto a column (2.4 cm x 30 cm, 136 ml) packed with Q-Sepharose Fast Flow (Pharmacia) resin equilibrated with 10 mM TrisCl, 25 mM KCl, 5 mM DTT, 10% glycerol, pH 7.8 (Q Sepharose buffer), and washed with 1 L of the same buffer. EPSPS was eluted with a linear gradient of Q Sepharose buffer going from 0.025 M to 0.40 M KCl (total volume of 1.4 L, 5 ml/min). Fractions were collected (15 ml) and assayed for EPSPS activity by the phosphate release assay. The fractions with the highest EPSPS activity (fractions 47-60) were pooled and the protein was precipitated by adding solid ammonium sulfate to 80% saturation and stirring for 1 hour. The precipitated protein was collected by centrifugation (20 minutes, 12000 rpm in a GSA Sorvall rotor), dissolved in Q Sepharose buffer (total volume of 14 ml), and dialyzed against the same buffer (2 x 1 L, 18 hours). The resulting dialyzed partially purified EPSPS extract (19 ml) was loaded (1.7 ml/min) onto a Mono Q 10/10 column (Pharmacia) equilibrated with Q Sepharose buffer, and washed with the same buffer (35 ml). EPSPS was eluted with a Hnear gradient of 0.025 M to 0.35 M KCl (total volume of 119 ml, 1.7 ml/min). Fractions were collected (1.7 ml) and assayed for EPSPS activity by the phosphate release assay. The fractions with the highest EPSPS activity (fractions 30-37) were pooled (6 ml). The Mono Q pool was made 1 M in ammonium sulfate by the addition of solid ammonium sulfate and 2 ml aliquots were chromatographed on a Phenyl Superose 5/5 column (Pharmacia) equilibrated with 100 mM TrisCl, 5 mM DTT, 1 M ammonium sulfate, 10% glycerol, pH 7.5 (Phenyl Superose buffer). Samples were loaded (1 ml/min), washed with Phenyl Superose buffer (10 ml), and eluted with a linear gradient of Phenyl Superose buffer going from 1 M to 0.00 M ammonium sulfate (total volume of 60 ml, 1 ml/min). Fractions were collected (1 ml) and assayed for EPSPS activity by the phosphate release assay. The fractions from each run with the highest EPSPS activity (fractions -36-40) were pooled together (10 ml, 2.5 mg protein). For N-terminal amino acid sequence determination, a portion of one fraction (#39 from run 1) was dialyzed against 50 mM NaHCθ 3 (2 1 L). The resulting pure EPSPS sample (0.9 ml, 77 μg protein) was found to exhibit a single N-terminal amino acid sequence of: XH(G)ASSRPATARKSS(G)LX(GXT)V(R)IPG(DXKXM) (SEQ ID NO:18). in this and all amino acid sequences to follow, the standard single letter nomenclature is used. All peptide structures represented in the following description are shown in conventional format wherein the amino group at the N-terminus appears to the left and the carboxyl group at the C-terminus at the right. Likewise, amino acid nomenclature for the naturally occurring amino acids found in protein is as follows: alanine (Ala;A), asparagine (Asn;N), aspartic acid (Asp;D), arginine (Arg;R), cysteine (Cys;C), glutamic acid (Glu;E), glutamine (Gln;Q), glycine (Gly;G), histidine (His;H), isoleucine (lle;l), leucine (Leu;L), lysine (Lys;K), methionine (Met;M), phenylalanine (Phe;F), proline (Pro;P), serine (Ser;S), threonine (Thr;T), tryptophan (Trp;W), tyrosine (Tyr;Y), and valine (Val;V). An "X" is used when the amino acid residue is unknown and parentheses designate that an unambiguous assignment is not possible and the amino acid designation within the parentheses is the most probable estimate based on known information. The remaining Phenyl Superose EPSPS pool was dialyzed against 50 mM TrisCl, 2 mM DTT, 10 mM KCl, 10% glycerol, pH 7.5 (2 x 1 L). An aliquot (0.55 ml, 0.61 mg protein) was loaded (1 ml/min) onto a Mono Q 5/5 column (Pharmacia) equilibrated with Q Sepharose buffer, washed with the same buffer (5 ml), and eluted with a linear gradient of Q Sepharose buffer going from 0-0.14 M KCl in 10 minutes, then holding at 0.14 M KCl (1 ml/min). Fractions were collected (1 ml) and assayed for EPSPS activity by the phosphate release assay and were subjected to SDSPAGE (10-15%, Phast System, Pharmacia, with silver staining) to determine protein purity. Fractions exhibiting a single band of protein by SDS-PAGE (22-25, 222 μg) were pooled and dialyzed against 100 mM ammonium bicarbonate, pH 8.1 (2 x 1 L, 9 hours). Trvspinolvsis and peptide sequencing of Agrobacterium sp strain CP4 EPSPS To the resulting pure Agrobacterium sp. strain CP4 EPSPS (111 μg) was added 3 μg of trypsin (Calbiochem), and the trypsinolysis reaction was allowed to proceed for 16 hours at 37°C. The tryptic digest was then chromatographed (lml/min) on a C 18 reverse phase HPLC column (Vydac) as previously described in Padgette et al. 1988 foτE. coli EPSPS. For all peptide purifications, 0.1% trifluoroacetic acid (TFA, Pierce) was designated buffer "RP-A" and 0.1% TFA in acetonitrile was buffer "RP-B". The gradient used for elution of the trypsinized Agrobacterium sp. CP4 EPSPS was: 0-8 minutes, 0% RP-B; 8-28 minutes, 0-15% RP-B; 28-40 minutes, 15-21% RP-B; 40-68 minutes, 21-49% RP-B; 68-72 minutes, 49-75% RP-B; 72-74 minutes, 75-100% RP-B. Fractions were collected (1 ml) and, based on the elution profile at 210 nm, at least 70 distinct peptides were produced from the trypsinized EPSPS. Fractions 40-70 were evaporated to dryness and redissolved in 150 μl each of 10% acetonitrile, 0.1% trifluoroacetic acid. The fraction 61 peptide was further purified on the C18 column by the gradient: 0-5 minutes, 0% RP-B; 5-10 minutes, 0-38% RP-B; 10-30 minutes, 38-45% B. Fractions were collected based on the UV signal at 210 nm. A large peptide peak in fraction 24 eluted at 42% RP-B and was dried down, resuspended as described above, and rechromatographed on the C18 column with the gradient: 0-5 minutes, 0% RP-B; 5-12 min, 0-38% RP-B; 12-15 min, 38-39% RP-B; 15-18 minutes, 39% RP-B; 18-20 minutes, 39-41% RP-B; 20-24 minutes, 41% RP-B; 24-28 minutes, 42% RP-B. The peptide in fraction 25, eluting at 41% RP-B and designated peptide 61-24-25, was subjected to N-terminal amino acid sequencing, and the following sequence was determined: APSM(I)(D)EYPILAV (SEQ ID NO:19). The CP4 EPSPS fraction 53 tryptic peptide was further purified by C18 HPLC by the gradient 0% B (5 minutes), 0-30% B (5-17 minutes), 30-40% B (17-37 minutes). The peptide in fraction 28, eluting at 34% B and designated peptide 53-28, was subjected to N-terminal amino acid sequencing, and the following sequence was determined: ITGLLEGEDVINTGK (SEQ ID NO: 20). In order to verify the CP4 EPSPS cosmid clone, a number of oligonucleotide probes were designed on the basis of the sequence of two of the tryptic sequences from the CP4 enzyme (Table III). The probe identified as MID was very low degeneracy and was used for initial screening. The probes identified as EDV-C and EDV-T were based on the same amino acid sequences and differ in one position (underlined in Table III below) and were used as confirmatory probes, with a positive to be expected only from one of these two probes. In the oligonucleotides below, alternate acceptable nucleotides at a particular position are designated by a "/" such as A/C/T. Table m Selected CP4 EPSPS peptide sequences and DNA probes PEPTIDE 61-24-25 APSM(I)(D)EYPILAV (SEQ ID NO: 19) Probe MID; 17-mer; mixed probe; 24-fold degenerate ATGATA/C/TGAC/TGAG/ATAC TCC (SEQ ID NO:21) PEPTIDE 53-28 ITGLLEGEDVINTGK (SEQ ID NO:20) Probe EDV-C; 17-mer; mixed probe; 48-fold degenerate GAA/GGAC/TGTA/C/G/TATA/C/TAA£AC (SEQ ID NO:22) Probe EDV-T; 17-mer; mixed probe; 48-fold degenerate GAA/GGAC/TGTA/C/G/TATA/C/TAAXAC (SEQ ID NO:23) The probes were labeled using gamma-32P-ATP and polynucleotide kinase. DNA from fourteen of the cosmids described above was restricted with 2_ coRI, transferred to membrane and probed with the olignucleotide probes. The conditions used were as follows: prehybridization was carried out in 6X SSC, 10X Denhardt's for 2-18 hour periods at 60°C, and hybridization was for 48-72 hours in 6X SSC, 10X Denhardt's, 100 μg/ml tRNA at 10°C below the T d for the probe. The T d of the probe was approximated by the formula 2°C x (A+T) + 4°C x (G+C). The filters were then washed three times with 6X SSC for ten minutes each at room temperature, dried and autoradiographed. Using the MID probe, an -9.9 kb fragment in the pMON17076 cosmid gave the only positive signal. This cosmid DNA was then probed with the EDV-C (SEQ ID NO:22) and EDV-T (SEQ ID NO:23) probes separately and again this -9.9 kb band gave a signal and only with the EDV-T probe. The combined data on the glyphosate tolerant phenotype, the complementation of the E. coli aroA- phenotype, the expression of a -45 Kd protein, and the hybridization to two probes derived from the CP4 EPSPS amino acid sequence strongly suggested that the pMON17076 cosmid contained the EPSPS gene. Localization and subcloning of the CP4 EPSPS gene The CP4 EPSPS gene was further localized as follows: a number of additional Southern analyses were carried out on different restriction digests of pMON17076 using the MID (SEQ ID NO:21) and EDV-T (SEQ ID NO:23) probes separately. Based on these analyses and on subsequent detailed restriction mapping of the pBlueScript (Stratagene) subclones of the -9.9 kb fragment from pMON17076, a 3.8 kb EcoRI- S all fragment was identified to which both probes hybridized. This analysis also showed that MID (SEQ ID NO:21) and EDV-T (SEQ ID NO:23) probes hybridized to different sides of BamΗl, Clal, and SαcII sites. This 3.8 kb fragment was cloned in both orientations in pBlueScript to form pMON17081 and pMON17082. The phenotypes imparted to E. coli by these clones were then determined. Glyphosate tolerance was determined following transformation into E. coli MM294 containing pGPl-2 (pBlueScript also contains a T7 promoter) on M9 agar media containing glyphosate at 3 mM. Both pMON17081 and pMON17082 showed glyphosate tolerant colonies at three days at 30°C at about half the size of the controls on the same media lacking glyphosate. This result suggested that the 3.8 kb fragment contained an intact EPSPS gene. The apparent lack of orientation-dependence of this phenotype could be explained by the presence of the T7 promoter at one side of the cloning sites and the lac promoter at the other. The aroA phenotype was determined in transformants of E. coli GB100 on M9 agar media lacking aromatic supplements. In this experiment, carried out with and without the Plac inducer IPTG, pMON17082 showed much greater growth than pMON17081, suggesting that the EPSPS gene was expressed from the Sail site towards the .EcoRI site. Nucleotide sequencing was begun from a number of restriction site ends, including the BamΗI site discussed above. Sequences encoding protein sequences that closely matched the N-terminus protein sequence and that for the tryptic fragment 53-28 (SEQ ID NO:20) (the basis of the EDV-T probe) (SEQ ID NO:23)were localized to the S all side of this α HI site. These data provided conclusive evidence for the cloning of the CP4 EPSPS gene and for the direction of transcription of this gene. These data coupled with the restriction mapping data also indicated that the complete gene was located on an -2.3 kb Xhόl fragment and this fragment was subcloned into pBlueScript. The nucleotide sequence of almost 2 kb of this fragment was determined by a combination of sequencing from cloned restriction fragments and by the use of specific primers to extend the sequence. The nucleotide sequence of the CP4 EPSPS gene and flanking regions is shown in Figure 3 (SEQ ID NO:2). The sequence corresponding to peptide 61-24-25 (SEQ ID NO: 19) was also located. The sequence was determined using both the Sequenase kit from IBI (International Biotechnologies Inc.) and the T7 sequencing Deaza Kit from Pharmacia. That the cloned gene encoded the EPSPS activity purified from the Agrobacterium sp. strain CP4 was verified in the following manner: By a series of site directed mutageneses, BglH and Ncol sites were placed at the N- terminus with the fMet contained within the iVcoI recognition sequence, the first internal Ncol site was removed (the second internal Ncol site was removed later), and a Sαcl site was placed after the stop codons. At a later stage the internal Notl site was also removed by site-directed mutagenesis. The following list includes the primers for the site-directed mutagenesis (addition or removal of restriction sites) of the CP4 EPSPS gene. Mutagenesis was carried out by the procedures of Kunkel et al. (1987), essentially as described in Sambrook et al. (1989). PRIMER BgNc (addition of Bglll and Ncol sites to N-terminus) CGTGGATAGATCTAGGAAGACAACCATGGCTCACGGTC (SEQ ID NO:24) PRIMER Sph2 (addition of Sphl site to N-terminus) GGATAGATTAAGGAAGACGCGCATGCTTCACGGTGCAAGC AGCC (SEQ ID NO:25) PRIMER SI (addition of Sαcl site immediately after stop codons) GGCTGCCTGATGAGCTCCACAATCGCCATCGATGG (SEQ ID NO:26) PRIMER Nl (removal of internal Notl recognition site) CGTCGCTCGTCGTGCGTGGCCGCCCTGACGGC (SEQ ID NO:27) PRIMER Ncol (removal of first internal Ncol recognition site) CGGGCAAGGCCATGCAGGCTATGGGCGCC (SEQ ID NO:28) PRIMER Nco2 (removal of second internal _VcoI recognition site) CGGGCTGCCGCCTGACTATGGGCCTCGTCGG (SEQ ID NO:29) This CP4 EPSPS gene was then cloned as a Ncol-BamHl N-terminal fragment plus a BamΗI-Sacl C-terminal fragment into a PrecA-genelOL expression vector similar to those described (Wong et al., 1988; Olins et al., 1988) to form pMON17101. The K m for PEP and the Kj for glyphosate were determined for the EPSPS activity in crude lysates of pMON17101/GB100 transformants following induction with nalidixic acid (Wong et al., 1988) and found to be the same as that determined for the purified and crude enzyme preparations from Agrobacterium sp. strain CP4. Characterization of the EPSPS gene from Achromobacter SP. strain LBAA and from Pseudomonas SP. strain PG2982 A cosmid bank of partially .__ indlll-restricted LBAA DNA was constructed in E. coli MM294 in the vector pHC79 (Hohn and Collins, 1980). This bank was probed with a full length CP4 EPSPS gene probe by colony hybridization and positive clones were identified at a rate of -1 per 400 cosmids. The LBAA EPSPS gene was further localized in these cosmids by Southern analysis. The gene was located on an -2.8 kb Xhόl fragment and by a series of sequencing steps, both from restriction fragment ends and by using the oligonucleotide primers from the sequencing of the CP4 EPSPS gene, the nucleotide sequence of the LBAA EPSPS gene was completed and is presented in Figure 4 (SEQ ID NO:4). The EPSPS gene from PG2982 was also cloned. The EPSPS protein was purified, essentially as described for the CP4 enzyme, with the following differences: Following the Sepharose CL-4B column, the fractions with the highest EPSPS activity were pooled and the protein precipitated by adding solid ammonium sulfate to 85% saturation and stirring for 1 hour. The precipitated protein was collected by centrifugation, resuspended in Q Sepharose buffer and following dialysis against the same buffer was loaded onto the column (as for the CP4 enzyme). After purification on the Q Sepharose column, -40 mg of protein in 100 mM Tris pH 7.8, 10% glycerol, 1 mM EDTA, 1 mM DTT, and 1 M ammonium sulfate, was loaded onto a Phenyl Superose (Pharmacia) column. The column was eluted at 1.0 ml minutes with a 40 ml gradient from 1.0 M to 0.00 M ammonium sulfate in the above buffer. Approximately 1.0 mg of protein from the active fractions of the Phenyl Superose 10/10 column was loaded onto a Pharmacia Mono P 5/10 Chromatofocusing column with a flow rate of 0.75 ml/minutes. The starting buffer was 25 mM bis-Tris at pH 6.3, and the column was eluted with 39 ml of Polybuffer 74, pH 4.0. Approximately 50 μg of the peak fraction from the Chromatofocusing column was dialyzed into 25 mM ammonium bicarbonate. This sample was then used to determine the N-terminal amino acid sequence. The N-terminal sequence obtained was: XHSASPKPATARRSE (where X = an unidentified residue) (SEQ ID NO:30). A number of degenerate oligonucleotide probes were designed based on this sequence and used to probe a library of PG2982 partial -HϊncZIII DNA in the cosmid pHC79 (Hohn and Collins, 1980) by colony hybridization under nonstringent conditions. Final washing conditions were 15 minutes with IX SSC, 0.1% SDS at 55°C. One probe with the sequence GCGGTBGCSGGYTTSGG (where B = C, G, or T; S = C or G, and Y = C or T) (SEQ ID NO:31) identified a set of cosmid clones. The cosmid set identified in this way was made up of cosmids of diverse Hindlll fragments. However, when this set was probed with the CP4 EPSPS gene probe, a cosmid containing the PG2982 EPSPS gene was identified (designated as cosmid 9C1 originally and later as pMON20107). By a series of restriction mappings and Southern analysis this gene was localized to a -2.8 kb Xhol fragment and the nucleotide sequence of this gene was determined. This DNA sequence (SEQ ID NO:6) is shown in Figure 5. There are no nucleotide differences between the EPSPS gene sequences from LBAA (SEQ ID NO:4) and PG2982 (SEQ ID NO:6). The kinetic parameters of the two enzymes are within the range of experimental error. A gene from PG2982 that imparts glyphosate tolerance in E. coli has been sequenced (Fitzgibbon, 1988; Fitzgibbon and Braymer, 1990). The sequence of the PG2982 EPSPS Class II gene shows no homology to the previously reported sequence suggesting that the glyphosate tolerant phenotype of the previous work is not related to EPSPS. Alternative Isolation Protocols for Other Class II EPSPS Structural Genes A number of Class II genes have been isolated and described here. It is clear that the initial gene cloning, that of the gene from CP4, was difficult due to the low degree of similarity between the Class I and Class II enzymes and genes. The identification of the other genes however was greatly facilitated by the use of this first gene as a probe. In the cloning of the LBAA EPSPS gene, the CP4 gene probe allowed the rapid identification of cosmid clones and the localization of the intact gene to a small restriction fragment and some of the CP4 sequencing primers were also used to sequence the LBAA (and PG2982) EPSPS gene(s). The CP4 gene probe was also used to confirm the PG2982 gene clone. The high degree of similarity of the Class II EPSPS genes may be used to identify and clone additional genes in much the same way that Class I EPSPS gene probes have been used to clone other Class I genes. An example of the latter was in the cloning of the A. thaliana EPSPS gene using the P. hybrida gene as a probe (Klee et al., 1987). Glyphosate tolerant EPSPS activity has been reported previously for EPSP synthases from a number of sources. These enzymes have not been characterized to any extent in most cases. The use of Class I and Class II EPSPS gene probes or antibody probes provide a rapid means of initially screening for the nature of the EPSPS and provide tools for the rapid cloning and characterization of the genes for such enzymes. Two of the three genes described were isolated from bacteria that were isolated from a glyphosate treatment facility (Strains CP4 and LBAA). The third (PG2982) was from a bacterium that had been isolated from a culture collection strain. This latter isolation suggests that exposure to glyphosate may not be a prerequisite for the isolation of high glyphosate tolerant EPSPS enzymes and that the screening of collections of bacteria could yield additional isolates. It is possible to enrich for glyphosate degrading or glyphosate resistant microbial populations (Quinn et al., 1988; Talbot et al., 1984) in cases where it was felt that enrichment for such microorganisms would enhance the isolation frequency of Class II EPSPS microorganisms. Additional bacteria containing class II EPSPS gene have also been identified. A bacterium called C12, isolated from the same treatment column beads as CP4 (see above) but in a medium in which glyphosate was supplied as both the carbon and phosphorus source, was shown by Southern analysis to hybridize with a probe consisting of the CP4 EPSPS coding sequence. This result, in conjunction with that for strain LBAA, suggests that this enrichment method facilitates the identification of .Class II EPSPS isolates. New bacterial isolates containing Class II EPSPS genes have also been identified from environments other than glyphosate waste treatment facilities. An inoculum was prepared by extracting soil (from a recently harvested soybean field in Jerseyville, Illinois) and a population of bacteria selected by growth at 28°C in Dworkin-Foster medium containing glyphosate at 10 mM as a source of carbon (and with cycloheximide at 100 μg/ml to prevent the growth of fungi). Upon plating on L-agar media, five colony types were identified. Chromosomal DNA was prepared from 2ml L-broth cultures of these isolates and the presence of a Class II EPSPS gene was probed using a the CP4 EPSPS coding sequence probe by Southern analysis under stringent hybridization and washing conditions. One of the soil isolates, S2, was positive by this screen. Relationships between different EPSPS genes The deduced amino acid sequences of a number of Class I and the Class II EPSPS enzymes were compared using the Bestfit computer program provided in the UWGCG package (Devereux et al. 1984). The degree of similarity and identity as determined using this program is reported. The degree of similarity/identity determined within Class I and Class II protein sequences is remarkably high, for instance, comparing E. coli with S. typhimurium (similarity/identity = 93%/88%) and even comparing E. coli with a plant EPSPS (Petunia hybrida; 72%/55%). This data is shown in Table IV. The comparison of sequences between Class I and Class II, however, shows only a very low degree of relatedness between the Classes (similarity/identity = 50-53%/23-30%). The display of the Bestfit analysis for the E.coli (SEQ ID NO:8) and CP4 (SEQ ID NO:3) sequences shows the positions of the conserved residues and is presented in Figure 6. Previous analyses of EPSPS sequences had noted the high degree of conservation of sequences of the enzymes and the almost invariance of sequences in two regions - the "20-35" and "95-107" regions (Gasser et al., 1988; numbered according to the Petunia EPSPS sequence) - and these regions are less conserved in the case of CP4 and LBAA when compared to Class I bacterial and plant EPSPS sequences (see Figure 6 for a comparison of the E . coli and CP4 EPSPS sequences with the E. coli sequence appearing as the top sequence in the Figure). The corresponding sequences in the CP4 Class π EPSPS are: PGDKSISHRSFMFGGL (SEQ ID NO:32) and LDFGNAATGCRLT (SEQ ID NO:33). These comparisons show that the overall relatedness of Class I and Class II is EPSPS proteins is low and that sequences in putative conserved regions have also diverged considerably. In the CP4 EPSPS an alanine residue is present at the "glycine 101" position. The replacement of the conserved glycine (from the "95-107" region) by an alanine results in an elevated Ki for glyphosate and in an elevation in the K m for PEP in Class I EPSPS. In the case of the CP4 EPSPS, which contains an alanine at this position, the K m for PEP is in the low range, indicating that the Class II enzymes differ in many aspects from the EPSPS enzymes heretofore characterized. Within the Class II isolates, the degree of similarity/identity is as high as that noted for that within Class I (Table IV). Figure 7 displays the Bestfit computer program alignment of the CP4 (SEQ ID NO:3) and LBAA (SEQ ID NO:5) EPSPS deduced amino acid sequences with the CP4 sequence appearing as the top sequence in the Figure. The symbols used in Figures 6 and 7 are the standard symbols used in the Bestfit computer program to designate degrees of similarity and identity. Table IV Comparison of relatedness of EPSPS protein sequences! Comparison between Class I and Class II EPSPS protein sequences E. coli vs. S. typhimurium 93.0 88.3 P. hybrida vs. E. coli 71.9 54.5 Comparison between Class II EPSPS protein sequences similarity identity Agrobacterium sp. strain CP4 vs. Achromobacter sp. strain LBAA 89.9 83.7 1 The EPSPS sequences compared here were obtained from the following references: E. coli, Rogers et al., 1983; S. typhimurium, Stalker et al., 1985; Petunia hybrida, Shah et al., 1986; B. pertussis, Maskell et al., 1988; and S. cereυisiae, Duncan et al., 1987. One difference that may be noted between the deduced amino acid sequences of the CP4 and LBAA EPSPS proteins is at position 100 where an Alanine is found in the case of the CP4 10 enzyme and a Glycine is found in the case of the LBAA enzyme. In the Class I EPSPS enzymes a Glycine is usually found in the equivalent position, i.e Glycine96 in E . coli and K. pneumoniae and GlycinelOl in Petunia. In the case of these three enzymes it has been reported that converting that Glycine to an Alanine results in -_ an elevation of the appKi for glyphosate and a concomitant elevation in the appKm for PEP (Kishore et al. 1986; Kishore and Shah, 1988; Sost and Amrhein, 1990), which, as discussed above, makes the enzyme less efficient especially under conditions of lower PEP concentrations. The GlycinelOO of the LBAA EPSPS 2 Q was converted to an Alanine and both the appKm for PEP and the appKi for glyphosate were determined for the variant. The Glycine lOOAlanine change was introduced by mutagenesis using the following primer: CGGCAATGCCGCCACCGGCGCGCGCC (SEQ ID NO:34) t~ and both the wild type and variant genes were expressed in E. coli in a RecA promoter expression vector (pMON17201 and pMON17264, respectively) and the appKm's and appKi's determined in crude ly sates. The data indicate that the appKi(glyphosate) for the G100A variant is elevated about 16-fold 30 (Table V). This result is in agreement with the observation of the importance of this G-A change in raising the appKi(glyphosate) in the Class I EPSPS enzymes. However, in contrast to the results in the Class I G-A variants, the appKm(PEP) in the Class II (LBAA) G-A variant is unaltered. This provides yet another distinction between the Class II and Class I EPSPS enzymes. Table V @ range of PEP: 2-40 μM * range of glyphosate: 0-310 μM; # range of glyphosate: 0-5000 μM. The LBAA G100A variant, by virtue of its superior kinetic properties, is capable of imparting improved glyphosate in planta. Modification and Resvnthesis of the Aεrobacterium sp. strain CP4 EPSPS Gene Sequence The EPSPS gene from Agrobacterium sp. strain CP4 contains sequences that could be inimical to high expression of the gene in plants. These sequences include potential polyadenylation sites that are often and A+T rich, a higher G+C% than that frequently found in plant genes (63% versus -50%), concentrated stretches of G and C residues, and codons that are not used frequently in plant genes. The high G+C% in the CP4 EPSPS gene has a number of potential consequences including the following: a higher usage of G or C than that found in plant genes in the third position in codons, and the potential to form strong hair-pin structures that may affect expression or stability of the RNA. The reduction in the G+C content of the CP4 EPSPS gene, the disruption of stretches of G's and C's, the elimination of potential polyadenylation sequences, and improvements in the codon usage to that used more frequently in plant genes, could result in higher expression of the CP4 EPSPS gene in plants. A synthetic CP4 gene was designed to change as completely as possible those inimical sequences discussed above. In summary, the gene sequence was redesigned to eliminate as much as possible the following sequences or sequence features (while avoiding the introduction of unnecessary restriction sites): stretches of G's and C's of 5 or greater; and A+T rich regions (predominantly) that could function as polyadenylation sites or potential RNA destabilization region The sequence of this gene is shown in Figure 8 (SEQ ID NO:9). This coding sequence was expressed in E. coli from the RecA promoter and assayed for EPSPS activity and compared with that from the native CP4 EPSPS gene. The apparent Km for PEP for the native and synthetic genes was 11.8 and 12.7, respectively, indicating that the enzyme expressed from the synthetic gene was unaltered. The N-terminus of the coding sequence was mutagenized to place an Sphl site at the ATG to permit the construction of the CTP2-CP4 synthetic fusion for chloroplast import. The following primer was used to accomplish this mutagenesis: GGACGGCTGCTTGCACCGTGAAGCATGCTTAAGCTTGGCGT AATCATGG (SEQ ID NO:35). Expression of Chloroplast Directed CP4 EPSPS The glyphosate target in plants, the 5-€noZpyruvyl-shikimate-3-phosphate synthase (EPSPS) enzyme, is located in the chloroplast. Many chloroplast-localized proteins, including EPSPS, are expressed from nuclear genes as precursors and are targeted to the chloroplast by a chloroplast transit peptide (CTP) that is removed during the import steps. Examples of other such chloroplast proteins include the small subunit (SSU) of Ribulose-l,5-bisphosphate carboxylase (RUBISCO), Ferredoxin, Ferredoxin oxidoreductase, the Light-harvesting-complex protein I and protein II, and Thior edoxin F. It has been demonstrated in vivo and in vitro that non-chloroplast proteins may be targeted to the chloroplast by use of protein fusions with a CTP and that a CTP sequence is sufficient to target a protein to the chloroplast. A CTP-CP4 EPSPS fusion was constructed between the Arabidopsis thaliana EPSPS CTP (Klee et al., 1987) and the CP4 EPSPS coding sequences. The Arabidopsis CTP was engineered by site-directed mutagenesis to place a Sphl restriction site at the CTP processing site. This mutagenesis replaced the Glu-Lys at this location with Cys-Met. The sequence of this CTP, designated as CTP2 (SEQ ID NO: 10), is shown in Figure 9. The N-terminus of the CP4 EPSPS gene was modified to place a Sphl site that spans the Met codon. The second codon was converted to one for leucine in this step also. This change had no apparent effect on the in vivo activity of CP4 EPSPS in E . coli as judged by rate of complementation of the aroA allele. This modified N-terminus was then combined with the Sαcl C-terminus and cloned downstream of the CTP2 sequences. The CTP2-CP4 EPSPS fusion was cloned into pBlueScript KS(+). This vector may be transcribed iTi vitro using the T7 polymerase and the RNA translated with 35S-Methionine to provide material that may be evaluated for import into chloroplasts isolated from Lactuca sativa using the methods described hereinafter (della-Cioppa et al., 1986, 1987). This template was transcribed in vitro using T7 polymerase and the 35S-methionine-labeled CTP2-CP4 EPSPS material was shown to import into chloroplasts with an efficiency comparable to that for the control Petunia EPSPS (control = 35S labeled PreEPSPS [pMON6140; della-Cioppa et al., 1986]). In another example the Arabidopsis EPSPS CTP, designated as CTP3, was fused to the CP4 EPSPS through an EcoRI site. The sequence of this CTP3 (SEQ ID NO:12) is shown in Figure 10. An EcoRI site was introduced into the Arabidopsis EPSPS mature region around amino acid 27, replacing the sequence -Arg-Ala-Leu-Leu- with -Arg-Ile-Leu-Leu- in the process. The primer of the following sequence was used to modify the N-terminus of the CP4 EPSPS gene to add an EcoRI site to effect the fusion to the CTP3: GGAAGACGCCCAGAATTCACGGTGCAAGCAGCCGG (SEQ ID NO:36) (the EcoRI site is underlined). This CTP3-CP4 EPSPS fusion was also cloned into the pBlueScript vector and the T7 expressed fusion was found to also import into chloroplasts with an efficiency comparable to that for the control Petunia EPSPS (pMON6140). A related series of CTPs, designated as CTP4 (Sphl) and CTP5 (EcoRI), based on the Petunia EPSPS CTP and gene were also fused to the Sphl- and EcoRI-modified CP4 EPSPS gene sequences. The Sphl site was added by site-directed mutagenesis to place this restriction site (and change the amino acid sequence to -Cys-Met-) at the chloroplast processing site. All of the CTP-CP4 EPSPS fusions were shown to import into chloroplasts with approximately equal efficiency. The CTP4 (SEQ ID NO: 14) and CTP5 (SEQ ID NO: 16) sequences are shown in Figures 11 and 12. A CTP2-LBAA EPSPS fusion was also constructed following the modification of the N-terminus of the LBAA EPSPS gene by the addition of a Sphl site. This fusion was also found to be imported efficiently into chloroplasts. By similar approaches, the CTP2-CP4 EPSPS and the CTP4-CP4 EPSPS fusion have also been shown to import efficiently into chloroplasts prepared from the leaf sheaths of corn. These results indicate that these CTP-CP4 fusions could also provide useful genes to impart glyphosate tolerance in monocot species. Those skilled in the art will recognize that various chimeric constructs can be made which utilize the functionality of a particular CTP to import a Class II EPSPS enzyme into the plant cell chloroplast. The chloroplast import of the Class II EPSPS can be determined using the following assay. Chloroplast Uptake Assay Intact chloroplasts are isolated from lettuce (Latuca sativa, var. longifolia) by centrifugation in Percoll/ficoll gradients as modified from Bartlett et al (1982). The final pellet of intact chloroplasts is suspended in 0.5 ml of sterile 330 mM sorbitol in 50 mM Hepes-KOH, pH 7.7, assayed for chlorophyll (Arnon, 1949), and adjusted to the final chlorophyll concentration of 4 mg/ml (using sorbitol/Hepes). The yield of intact chloroplasts from a single head of lettuce is 3-6mg chlorophyll. A typical 300 μl uptake experiment contained 5 mM ATP, 8.3 mM unlabeled methionine, 322 mM sorbitol, 58.3 mM Hepes-KOH (pH 8.0), 50 μl reticulocyte lysate translation products, and intact chloroplasts from L. sativa (200 μg chlorophyll). The uptake mixture is gently rocked at room temperature (in 10 x 75 mm glass tubes) directly in front of a fiber optic illuminator set at maximum light intensity (150 Watt bulb). Aliquot samples of the uptake mix (about 50 μl) are removed at various times and fractionated over 100 μl silicone-oil gradients (in 150 μl polyethylene tubes) by centrifugation at 11,000 X g for 30 seconds. Under these conditions, the intact chloroplasts form a pellet under the silicone-oil layer and the incubation medium (containing the reticulocyte lysate) floats on the surface. After centrifugation, the silicone-oil gradients are immediately frozen in dry ice. The chloroplast pellet is then resuspended in 50-100 μl of lysis buffer (10 mM Hepes-KOH pH 7.5, 1 mM PMSF, 1 mM benzamidine, 5 mM e-amino -n- caproic acid, and 30 μg/ml aprotinin) and centrifuged at 15,000 X g for 20 minutes to pellet the thylakoid membranes. The clear supernatant (stromal proteins) from this spin, and an aliquot of the reticulocyte lysate incubation medium from each uptake experiment, are mixed with an equal volume of 2X SDS-PAGE sample buffer for electrophoresis (Laemmli, 1970). SDS-PAGE is carried out according to Laemmli (1970) in 3-17% (w/v) acrylamide slab gels (60 mm X 1.5 mm) with 3% (w/v) acrylamide stacking gels (5 mm X 1.5 mm). The gel is fixed for 20-30 min in a solution with 40% methanol and 10% acetic acid. Then, the gel is soaked in EN3HANCE™ (DuPont) for 20-30 minutes, followed by drying the gel on a gel dryer. The gel is imaged by autoradiography, using an intensifying screen and an overnight exposure to determine whether the CP4 EPSPS is imported into the isolated chloroplasts. PLANT TRANSFORMATION Plants which can be made glyphosate tolerant by practice of the present invention include, but are not limited to, soybean, cotton, corn, canola, oil seed rape, flax, sugarbeet, sunflower, potato, tobacco, tomato, wheat, rice, alfalfa and lettuce as well as various tree, nut and vine species. A double-stranded DNA molecule of the present invention ("chimeric gene") can be inserted into the genome of a plant by any suitable method. Suitable plant transformation vectors include those derived from a Ti plasmid of Agrobacterium tumefaciens, as well as those disclosed, e.g., by Herrera-Estrella (1983), Bevan (1984), Klee (1985) and EPO publication 120,516 (Schilperoort et al.). In addition to plant transformation vectors derived from the Ti or root-inducing (Ri) plasmids of Agrobacterium, alternative methods can be used to insert the DNA constructs of this invention into plant cells. Such methods may involve, for example, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery via microprojectile bombardment, and transformation using viruses or pollen. Class II EPSPS Plant transformation vectors Class II EPSPS DNA sequences may be engineered into vectors capable of transforming plants by using known techniques. The following description is meant to be illustrative and not to be read in a limiting sense. One of ordinary skill in the art would know that other plasmids, vectors, markers, promoters, etc. would be used with suitable results. The CTP2-CP4 EPSPS fusion was cloned as a BgZII-EcoRI fragment into the plant vector pMON979 (described below) to form pMON17110, a map of which is presented in Figure 13. In this vector the CP4 gene is expressed from the enhanced CaMV35S promoter (E35S; Kay et al. 1987). A FMV35S promoter construct (pMON17116) was completed in the following way: The Sall-Notl and the Notl-Bglll fragments from pMON979 containing the Spc/AAC(3)-III/o riV and the pBR322/Right Border/NOS 3VCP4 EPSPS gene segment from pMON17110 were ligated with the Xhol-Bglϊl FMV35S promoter fragment from pMON981. These vectors were introduced into tobacco, cotton and canola. A series of vectors was also completed in the vector pMON977 in which the CP4 EPSPS gene, the CTP2-CP4 EPSPS fusion, and the CTP3-CP4 fusion were cloned as Bglll-Sacl fragments to form pMON17124, pMON17119, and pMON17120, respectively. These plasmids were introduced into tobacco. A pMON977 derivative containing the CTP2-LBAA EPSPS gene was also completed (pMON17206) and introduced into tobacco. The pMON979 plant transformation/expression vector was derived from pMON886 (described below) by replacing the neomycin phosphotransferase typell (KAN) gene in pMON886 with the 0.89 kb fragment containing the bacterial gentamicin-3-N-acetyltransferase type III (AAC(3)-III) gene (Hayford et al., 1988). The chimeric P-35S/AA(3)-III NOS 3' gene encodes gentamicin resistance which permits selection of transformed plant cells. pMON979 also contains a 0.95 kb expression cassette consisting of the enhanced CaMV 35S promoter (Kay et al., 1987), several unique restriction sites, and the NOS 3' end (P-En-CaMV35S/NOS 3 * ). The rest of the pMON979 DNA segments are exactly the same as in pMON886. Plasmid pMON886 is made up of the following segments of DNA. The first is a 0.93 kb Aval to engineered-EcoRV fragment isolated from transposon Tn7 that encodes bacterial spectinomycin/streptomycin resistance (Spc/Str), which is a determinant for selection in E. coli and Agrobacterium tumefaciens. This is joined to the 1.61 kb segment of DNA encoding a chimeric kanamycin resistance which permits selection of transformed plant cells. The chimeric gene (P-35S/KAN/NOS 3') consists of the cauliflower mosaic virus (CaMV) 35S promoter, the neomycin phosphotransferase typell (KAN) gene, and the 3'-nontranslated region of the nopaline synthase gene (NOS 3') (Fraley et al., 1983). The next segment is the 0.75 kb oriV containing the origin of replication from the RK2 plasmid. It is joined to the 3.1 kb Sail to Pvul segment of pBR322 (or£322) which provides the origin of replication for maintenance in E. coli and the bom site for the conjugational transfer into the Agrobacterium tumefaciens cells. The next segment is the 0.36 kb Pvul to BcZI from pTiT37 that carries the nopaline- type T-DNA right border (Fraley et al., 1985). The pMON977 vector is the same as pMON981 except for the presence of the P-En-CaMV35S promoter in place of the FMV35S promoter (see below). The pMON981 plasmid contains the following DNA segments: the 0.93 kb fragment isolated from transposon Tn7 encoding bacterial spectinomycin/streptomycin resistance [Spc/Str; a determinant for selection in E. coli and Agrobacterium tumefaciens (Fling et al., 1985)]; the chimeric kanamycin resistance gene engineered for plant expression to allow selection of the transformed tissue, consisting of the 0.35 kb cauliflower mosaic virus 35S promoter (P-35S) (Odell et al., 1985), the 0.83 kb neomycin phosphotransferase typell gene (KAN), and the 0.26 kb 3'-nontranslated region of the nopaline synthase gene (NOS 3') (Fraley et al., 1983); the 0.75 kb origin of replication from the RK2 plasmid (oriV) (Stalker et al., 1981); the 3.1 kb Sail to Pvul segment of pBR322 which provides the origin of replication for maintenance in E. coli (ori-322) and the bom site for the conjugational transfer into the Agrobacterium tumefaciens cells, and the 0.36 kb Pvul to Bc I fragment from the pTiT37 plasmid containing the nopaline-type T-DNA right border region (Fraley et al., 1985). The expression cassette consists of the 0.6 kb 35S promoter from the figwort mosaic virus (P-FMV35S) 'Gowda et al., 1989) and the 0.7 kb 3' non-translated region of the pea rbcS-E9 gene (E9 3') (Coruzzi et al., 1984, and Morelli et al., 1985). The 0.6 kb Sspl fragment containing the FMV35S promoter (Figure 1) was engineered to place suitable cloning sites downstream of the transcriptional start site. The C TP2-CP4syn gene fusion was introduced into plant expression vectors (including pMON981, to form pMON17131; Figure 14) and transformed into tobacco, canola, potato, tomato, sugarbeet, cotton, lettuce, cucumber, oil seed rape, poplar, and Arabidopsis. The plant vector containing the Class II EPSPS gene may be mobilized into any suitable Agrobacterium strain for transformation of the desired plant species. The plant vector may be mobilized into an ABI Agrobacterium strain. A suitable ABI strain is the A208 Agrobacterium tumefaciens carrying the disarmed Ti plasmid pTiC58 (pMP90RK) (Koncz and Schell, 1986). The Ti plasmid does not carry the T-DNA phytohormone genes and the strain is therefore unable to cause the crown gall disease. Mating of the plant vector into ABI was done by the triparental conjugation system using the helper plasmid pRK2013 (Ditta et al., 1980). When the plant tissue is incubated with the ABI::plant vector conjugate, the vector is transferred to the plant cells by the vir functions encoded by the disarmed pTiC58 plasmid. The vector opens at the T-DNA right border region, and the entire plant vector sequence may be inserted into the host plant chromosome. The pTiC58 Ti plasmid does not transfer to the plant cells but remains in the Agrobacterium. Class II EPSPS free DNA vectors Class II EPSPS genes may also be introduced into plants through direct delivery methods. A number of direct delivery vectors were completed for the CP4 EPSPS gene. The vector pMON 13640, a map of which is presented in Figure 15, is described here. The plasmid vector is based on a pUC plasmid (Vieira and Messing, 1987) containing, in this case, the nptll gene (kanamycin resistance; KAN) from Tn903 to provide a selectable marker in E. coli. The CTP4-EPSPS gene fusion is expressed from the P-FMV35S promoter and contains the NOS 3' polyadenylation sequence fragment and from a second cassette consisting of the E35S promoter, the CTP4-CP4 gene fusion and the NOS 3' sequences. The scoreable GUS marker gene (Jefferson et al. 1987) is expressed from the mannopine synthase promoter (P-MAS; Velten et al., 1984) and the soybean 7S storage protein gene 3' sequences (Schuler et al., 1982). Similar plasmids could also be made in which CTP-CP4 EPSPS fusions are expressed from the enhanced CaMV35S promoter or other plant promoters. Other vectors could be made that are suitable for free DNA delivery into plants and such are within the skill of the art and contemplated to be within the scope of this disclosure. PLANT REGENERATION When expression of the Class II EPSPS gene is achieved in transformed cells (or protoplasts), the cells (or protoplasts) are regenerated into whole plants. Choice of methodology for the regeneration step is not critical, with suitable protocols being available for hosts from Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, etc.), Cucurbitaceae (melons and cucumber), Gramineae (wheat, rice, corn, etc.), Solanaceae (potato, tobacco, tomato, peppers), various floral crops as well as various trees such as poplar or apple, nut crops or vine plants such as grapes. See, e.g., Ammirato, 1984; Shimamoto, 1989; Fromm, 1990; Vasil, 1990. The following examples are provided to better elucidate the practice of the present invention and should not be interpreted in any way to limit the scope of the present invention. Those skilled in the art will recognize that various modifications, truncations, etc. can be made to the methods and genes described herein while not departing from the spirit and scope of the present invention. In the examples that follow, EPSPS activity in plants is assayed by the following method. Tissue samples were collected and immediately frozen in liquid nitrogen. One gram of young leaf tissue was frozen in a mortar with liquid nitrogen and ground to a fine powder with a pestle. The powder was then transferred to a second mortar, extraction buffer was added (1 ml /gram), and the sample was ground for an additional 45 seconds. The extraction buffer for Canola consists of 100 mM Tris, 1 mM EDTA, 10 % glycerol, 5 mM DTT, 1 mM BAM, 5 mM ascorbate, 1.0 mg/ml BSA, pH 7.5 (4°C). The extraction buffer for tobacco consists of 100 mM Tris, 10 mM EDTA, 35 mM KCl, 20 % glycerol, 5 mM DTT, 1 mM BAM, 5 mM ascorbate, 1.0 mg/ml BSA, pH 7.5 (4°C). The mixture was transferred to a microfuge tube and centrifuged for 5 minutes. The resulting supernatants were desalted on spin G-50 (Pharmacia) columns, previously equilibrated with extraction buffer (without BSA), in 0.25 ml aliquots. The desalted extracts were assayed for EPSP synthase activity by radioactive HPLC assay. Protein concentrations in samples were determined by the BioRad microprotein assay with BSA as the standard. Protein concentrations were determined using the BioRad Microprotein method. BSA was used to generate a standard curve ranging from 2 - 24 μg. Either 800 μl of standard or diluted sample was mixed with 200 μl of concentrated BioRad Bradford reagent. The samples were vortexed and read at A(595) after - 5 minutes and compared to the standard curve. EPSPS enzyme assays contained HEPES (50 mM), shikimate-3-phosphate (2 mM), NH 4 molybdate (0.1 mM) and KF (5 mM), with or without glyphosate (0.5 or 1.0 mM). The assay mix (30 μl) and plant extract (10 μl) were preincubated for 1 minute at 25°C and the reactions were initiated by adding !■ *<_ -PEP (1 mM). The reactions were quenched after 3 minutes with 50 μl of 90% EtOH/O.lM HO Ac, pH 4.5. The samples were spun at 6000 rpm and the resulting supernatants were analyzed for 14C-EPSP production by HPLC. Percent resistant EPSPS is calculated from the EPSPS activities with and without glyphosate. The percent conversion of ι*C labeled PEP to ι C EPSP was determined by HPLC radioassay using a C18 guard column (Brownlee) and an AX100 HPLC column (0.4 X 25 cm, Synchropak) with 0.28 M isocratic potassium phosphate eluant, pH 6.5, at 1 ml/min. Initial velocities were calculated by multiplying fractional turnover per unit time by the initial concentration of the labeled substrate (1 mM). The assay was linear with time up to - 3 minutes and 30% turnover to EPSPS. Samples were diluted with 10 mM Tris, 10% glycerol, 10 mM DTT, pH 7.5 (4°C) if necessary to obtain results within the linear range. In these assays DL-dithiotheitol (DTT), benzamidine (BAM), and bovine serum albumin (BSA, essentially globulin free) were obtained from Sigma. Phosphoe/io Zpyruvate (PEP) was from Boehringer Mannheim and phosphoenoZ-[l-i4C]pyruvate (28 mCi mmol) was from Amersham. EXAMP E 1 Transformed tobacco plants have been generated with a number of the Class II EPSPS gene vectors containing the CP4 EPSPS DNA sequence as described above with suitable expression of the EPSPS. These transformed plants exhibit glyphosate tolerance imparted by the Class II CP4 EPSPS. Transformation of tobacco employs the tobacco leaf disc transformation protocol which utilizes healthy leaf tissue about 1 month old. After a 15-20 minutes surface sterilization with 10% Clorox plus a surfactant, the leaves are rinsed 3 times in sterile water. Using a sterile paper punch, leaf discs are punched and placed upside down on MS104 media (MS salts 4.3 g/1, sucrose 30 g 1, B5 vitamins 500X 2 ml/1, NAA 0.1 mg/1, and BA 1.0 mg 1) for a 1 day prec ulture. The discs are then inoculated with an overnight culture of a disarmed Agrobacterium ABI strain containing the subject vector that had been diluted 1/5 (ie: about 0.6 OD). The inoculation is done by placing the discs in centrifuge tubes with the culture. After 30 to 60 seconds, the Hquid is drained off and the discs were blotted between sterile filter paper. The discs are then placed upside down on MS104 feeder plates with a filter disc to co-culture. After 2-3 days of co-culture, the discs are transferred, still upside down, to selection plates with MS104 media. After 2-3 weeks, callus tissue formed, and individual clumps are separated from the leaf discs. Shoots are cleanly cut from the callus when they are large enough to be distinguished from stems. The shoots are placed on hormone-free rooting media (MSO: MS salts 4.3 g/1, sucrose 30 g1, and B5 vitamins 500X 2 ml/1) with selection for the appropriate antibiotic resistance. Root formation occurred in 1-2 weeks. Any leaf callus assays are preferably done on rooted shoots while still sterile. Rooted shoots are then placed in soil and kept in a high humidity environment (ie: plastic containers or bags). The shoots are hardened off by gradually exposing them to ambient humidity conditions. Expression of CP4 EPSPS protein in transformed plants Tobacco cells were transformed with a number of plant vectors containing the native CP4 EPSPS gene, and using different promoters and/or CTP's. Preliminary evidence for expression of the gene was given by the ability of the leaf tissue from antibiotic selected transformed shoots to recallus on glyphosate. In some cases, glyphosate tolerant callus was selected directly following transformation. The level of expression of the CP4 EPSPS was determined by the level of glyphosate tolerant EPSPS activity (assayed in the presence of 0.5 mM glyphosate) or by Western blot analysis using a goat anti-CP4 EPSPS antibody. The Western blots were quantitated by densitometer tracing and comparison to a standard curve established using purified CP4 EPSPS. These data are presented as % soluble leaf protein. The data from a number of transformed plant lines and transformation vectors are presented in Table VI below. Tahle VI E_qιres___on of CP4 EPSPS In JransFnrmv ή tobncnn ti m . Vector pMON17110 pMON17110 pMON17116 pMON17119 pMON17119 pMON17119 ** Glyphosate tolerant EPSPS activity was also demonstrated in leaf extracts for these plants. Glyphosate tolerance has also been demonstrated at the whole plant level in transformed tobacco plants. In tobacco, R 0 transformants of CTP2-CP4 EPSPS were sprayed at 0.4 lb/acre (0.448 kg/hectare), a rate sufficient to kill control non-transformed tobacco plants corresponding to a rating of 3, 1 and 0 at days 7, 14 and 28, respectively, and were analyzed vegetatively and reproductively (Table VII). TableVπ Glyphosate tn anw. in 1^ tobacco CP4 ransformants Spray rate = 0.4 lb acre (0.448kg/hectare) Vector/Plant # Scor * Vegetative Fertile day7 day 14 day 28 pMON1711025313 6 4 2 no pMON17110 25329 9 10 10 yes pMON17119_25106 9 9 10 yes * Plants are evaluated on a numerical scoring system of 0-10 where a vegetative score of 10 represents no damage relative to nonsprayed controls and 0 represents a dead plant. Reproductive scores (Fertile) are determined at 28 days after spraying and are evaluated as to whether or not the plant is fertile. EXAMPLE ? Canola plants were transformed with the pMON17110, pMON17116, and pMON17131 vectors and a number of plant lines of the transformed canola were obtained which exhibit glyphosate tolerance. Plant Material Seedlings of Brassica napus cv Westar were established in 2 inch (~ 5 cm) pots containing Metro Mix 350. They were grown in a growth chamber at 24°C, 16/8 hour photoperiod, Ught intensity of 400 uEm-Zsec- 1 (HID lamps). They were fertilized with Peters 20-10-20 General Purpose Special. After 2 1/2 weeks they were transplanted to 6 inch (~ 15 cm) pots and grown in a growth chamber at 15/10°C day/night temperature, 16/8 hour photoperiod, light intensity of 800 uEm-2sec-i (HID lamps). They were fertilized with Peters 15-30-15 Hi-Phos Special. Transformation/Selection/Regeneration Four terminal internodes from plants just prior to bolting or in the process of bolting but before flowering were removed and surfaced sterilized in 70% v/v ethanol for 1 minute, 2% w/v sodium hypochlorite for 20 minutes and rinsed 3 times with sterile deionized water. Stems with leaves attached could be refrigerated in moist plastic bags for up to 72 hours prior to sterilization. Six to seven stem segments were cut into 5mm discs with a Redco Vegetable Sheer 200 maintaining orientation of basal end. The Agrobacterium was grown overnight on a rotator at 24°C in 2mls of Luria Broth containing 50mg/l kanamycin, 24mg/l chloramphenicol and lOOmg/1 spectinomycin. A 1:10 dilution was made in MS (Murashige and Skoog) media giving approximately 9xl0 8 cells per ml. This was confirmed with optical density readings at 660 mu. The stem discs (explants) were inoculated with 1.0ml of Agrobacterium and the excess was aspirated from the explants. The explants were placed basal side down in petri plates containing 1/lOX standard MS salts, B5 vitamins, 3% sucrose, 0.8% agar, pH 5.7, l.Omg/1 6-benzyladenine (BA). The plates were layered with 1.5ml of media containing MS salts, B5 vitamins, 3% sucrose, pH 5.7, 4.0mg/l p-chlorophenoxyacetic acid, 0.005mg/l kinetin and covered with sterile filter paper. Following a 2 to 3 day co-culture, the explants were transferred to deep dish petri plates containing MS salts, B5 vitamins, 3% sucrose, 0.8% agar, pH 5.7, lmg/1 BA, 500mg/l carbenicillin, 50mg/l cefotaxime, 200 mg/1 kanamycin or 175mg/l gentamicin for selection. Seven explants were placed on each plate. After 3 weeks they were transferred to fresh media, 5 explants per plate. The explants were cultured in a growth room at 25°C, continuous light (Cool White). Expr ssion Assay After 3 weeks shoots were excised from the explants. Leaf recallusing assays were initiated to confirm modification of R 0 shoots. Three tiny pieces of leaf tissue were placed on recallusing media containing MS salts, B5 vitamins, 3% sucrose, 0.8% agar, pH 5.7, 5.0mg/l BA, 0.5mg/l naphthalene acetic acid (NAA), 500mgl carbenicillin, 50mg/l cefotaxime and 200mg/l kanamycin or gentamicin or 0.5mM glyphosate. The leaf assays were incubated in a growth room under the same conditions as explant culture. After 3 weeks the leaf recallusing assays were scored for herbicide tolerance (callus or green leaf tissue) or sensitivity (bleaching). Transplantation At the time of excision, the shoot stems were dipped in Rootone® and placed in 2 inch (~ 5 cm) pots containing Metro-Mix 350 and placed in a closed humid environment. They were placed in a growth chamber at 24°C, 16/8 hour photoperiod, 400 uE m -isec-2(HID lamps) for a hardening-off period of approximately 3 weeks. The seed harvested from R D plants is Ri seed which gives rise to Ri plants. To evaluate the glyphosate tolerance of an R 0 plant, its progeny are evaluated. Because an R 0 plant is assumed to be hemizygous at each insert location, selfing results in maximum genotypic segregation in the Ri. Because each insert acts as a dominant allele, in the absence of linkage and assuming only one hemizygous insert is required for tolerance expression, one insert would segregate 3:1, two inserts, 15:1, three inserts 63:1, 5 etc. Therefore, relatively few Ri plants need be grown to find at least one resistant phenotype. Seed from an R 0 plant is harvested, threshed, and dried before planting in a glyphosate spray test. Various techniques have been used to grow the plants for Ri spray evaluations. Tests are conducted in both greenhouses and growth chambers. Two planting systems are used; - 10 cm pots or plant trays containing 32 or 36 cells. Soil used for planting is either Metro 350 plus three types of slow release fertilizer or plant Metro - j c 350. Irrigation is either overhead in greenhouses or sub-irrigation in growth chambers. Fertilizer is applied as required in irrigation water. Temperature regimes appropriate for canola were maintained. A sixteen hour photoperiod was maintained. At the onset of flowering, plants are transplanted to -15 cm pots for seed 2 β production. A spray "batch" consists of several sets of Ri progenies all sprayed on the same date. Some batches may also include evaluations of other than Ri plants. Each batch also includes sprayed and unsprayed non-transgenic genotypes 25 representing the genotypes in the particular batch which were putatively transformed. Also included in a batch is one or more non-segregating transformed genotypes previously identified as having some resistance. Two- six plants from each individual R 0 progeny are 30 not sprayed and serve as controls to compare and measure the glyphosate tolerance, as well as to assess any variability not induced by the glyphosate. When the other plants reach the 2-4 leaf stage, usually 10 to 20 days after planting, glyphosate is applied at rates varying from 0.28 to 1.12 kg/ha, depending on objectives of the study. Low rate technology using low volumes has been adopted. A laboratory track sprayer has been calibrated to deliver a rate equivalent to field conditions. A scale of 0 to 10 is used to rate the sprayed plants for vegetative resistance. The scale is relative to the unsprayed plants from the same R 0 plant. A 0 is death, while a 10 represents no visible difference from the unsprayed plant. A higher number between 0 and 10 represents progressively less damage as compared to the unsprayed plant. Plants are scored at 7, 14, and 28 days after treatment (DAT), or until bolting, and a line is given the average score of the sprayed plants within an R o plant family. Six integers are used to qualitatively describe the degree of reproductive damage from glyphosate: 0: No floral bud development 2: Floral buds present, but aborted prior to opening 4: Flowers open, but no anthers, or anthers fail to extrude past petals 6: Sterile anthers 8: Partially sterile anthers 10: Fully fertile flowers Plants are scored using this scale at or shortly after initiation of flowering, depending on the rate of floral structure development. Expression of EPSPS in Canola After the 3 week period, the transformed canola plants were assayed for the presence of glyphosate tolerant EPSPS activity (assayed in the presence of glyphosate at 0.5mM). The results are shown in Table VIII. Table Vm Emression of CP4 TCPSPS in tranrformβ Canola plants % resistant EPSPS Vector Control pMON17110 pMON17110 pMON17110 pMON17110 pMON17110 pMON17110 pMON17110 pMON17110 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 pMON17116 ♦ assayed in the presence of 1.0 mM glyphosate Ri transformants of canola were then grown in a growth chamber and sprayed with glyphosate at 0.56 kg/ha (kilogram/hectare) and rated vegetatively. These results are shown in Table IXA - IXC. It is to be noted that expression of glyphosate resistant EPSPS in all tissues is preferred to observe optimal glyphosate tolerance phenotype in these transgenic plants. In the Tables below, only expression results obtained with leaf tissue are described. Table IXA Glyphosate tolerance in Class II EPSPS canola R 3 transformants (pMON17110 = P-E35S; pMON17116 = P-FMV35S; Rl plants; Spray rate = 0.56 kg ha) Table KB Glyphosate tolerance in Class π EPSPS canola Rj _raτι_fnnnnntg (pMON17131 = P-FMV35S; RI plants; Spray rate = 0.84 kg ha) Vector/Plant No. Vegetative score ** Reproductive score dav 14 dav 28 plant. The data obtained for the Class II EPSPS transformants may be compared to glyphosate tolerant Class I EPSP transformants in which the same promoter is used to express the EPSPS genes and in which the level of glyphosate tolerant EPSPS activity was comparable for the two types of transformants. A comparison of the data of pMON17110 [in Table IXA] and pMON17131 [Table IXB] with that for pMON899 [in Table IXC; the Class I gene in pMON899 is that from A. thaliana {Klee et al., 1987} in which the glycine at position 101 was changed to an alanine] illustrates that the Class II EPSPS is at least as good as that of the Class I EPSPS. An improvement in vegetative tolerance of Class II EPSPS is apparent when one takes into account that the Class II plants were sprayed at twice the rate and were tested as Ri plants. EXAMPLE 3 Soybean plants were transformed with the pMON13640 (Figure 15) vector and a number of plant lines of the transformed soybean were obtained which exhibit glyphosate tolerance. Soybean plants are transformed with pMON13640 by the method of microprojectile injection using particle gun technology as described in Christou et al. (1988). The seed harvested from R 0 plants is Ri seed which gives rise to Ri plants. To evaluate the glyphosate tolerance of an R 0 plant, its progeny are evaluated. Because an R 0 plant is assumed to be hemizygous at each insert location, selfing results in maximum genotypic segregation in the Ri. Because each insert acts as a dominant allele, in the absence of linkage and assuming only one hemizygous insert is required for tolerance expression, one insert would segregate 3:1, two inserts, 15:1, three inserts 63:1, etc. Therefore, relatively few Ri plants need be grown to find at least one resistant phenotype. Seed from an R 0 soybean plant is harvested, and dried before planting in a glyphosate spray test. Seeds are planted into 4 inch (~5cm) square pots containing Metro 350. Twenty seedlings from each Ro plant is considered adequate for testing. Plants are maintained and grown in a greenhouse environment. A 12.5-14 hour photoperiod and temperatures of 30°C day and 24°C night is regulated. Water soluble Peters Pete Lite fertilizer is applied as needed. A spray "batch" consists of several sets of Ri progenies all sprayed on the same date. Some batches may also include evaluations of other than Ri plants. Each batch also includes sprayed and unsprayed non-transgenic genotypes representing the genotypes in the particular batch which were putatively transformed. Also included in a batch is one or more non-segregating transformed genotypes previously identified as having some resistance. One to two plants from each individual R 0 progeny are not sprayed and serve as controls to compare and measure the glyphosate tolerance, as well as to assess any variability not induced by the glyphosate. When the other plants reach the first trifoliate leaf stage, usually 2-3 weeks after planting, glyphosate is applied at a rate equivalent of 128 ozJacre (8.895kg/ha) of Roundup®. A laboratory track sprayer has been calibrated to deliver a rate equivalent to those conditions. A vegetative score of 0 to 10 is used. The score is relative to the unsprayed progenies from the same R 0 plant. A 0 is death, while a 10 represents no visible difference from the unsprayed plant. A higher number between 0 and 10 represents progressively less damage as compared to the unsprayed plant. Plants are scored at 7, 14, and 28 days after treatment (DAT). The data from the analysis of one set of transformed and control soybean plants are described on Table X and show that the CP4 EPSPS gene imparts glyphosate tolerance in soybean also. Table X Glyphosate tolerance in Class I EPSPS soybean transom- ffllfr. (P-E35S, P-FMV35S; RO plants; Spray rate - 128 os_/acre) Vector/Plant No. Vegetative score dav 7 dav 14 dav 28 7 10 7 0 0 The CP4 EPSPS gene may be used to select transformed plant material directly on media containing glyphosate. The ability to select and to identify transformed plant material depends, in most cases, on the use of a dominant selectable marker gene to enable the preferential and continued growth of the transformed tissues in the presence of a normally inhibitory substance. Antibiotic resistance and herbicide tolerance genes have been used almost exclusively as such dominant selectable marker genes in the presence of the corresponding antibiotic or herbicide. The nptll/kanamycin selection scheme is probably the most frequently used. It has been demonstrated that CP4 EPSPS is also a . useful and perhaps superior selectable marker/selection scheme for producing and identifying transformed plants. A plant transformation vector that may be used in this scheme is pMON17227 (Figure 16). This plasmid resembles many of the other plasmids described infra and is essentially composed of the previously described bacterial replicon system that enables this plasmid to replicate in E . coli and to be introduced into and to replicate in Agrobacterium, the bacterial selectable marker gene (Spc/Str), and located between the T-DNA right border and left border is the CTP2-CP4 synthetic gene in the FMV35S promoter -E9 3' cassette. This plasmid also has single sites for a number of restriction enzymes, located within the borders and outside of the expression cassette. This makes it possible to easily add other genes and genetic elements to the vector for introduction into plants. The protocol for direct selection of transformed plants on glyphosate is outlined for tobacco. Explants are prepared for pre-culture as in the standard procedure as described in Example 1: surface sterilization of leaves from 1 month old tobacco plants (15 minutes in 10% clorox + surfactant; 3X dH^O washes); explants are cut in 0.5 x 0.5 cm squares, removing leaf edges, mid-rib, tip, and petiole end for uniform tissue type; explants are placed in single layer, upside down, on MS104 plates + 2 ml 4C005K media to moisten surface; pre-culture 1-2 days. Explants are inoculated using overnight culture of Agrobacterium containing the plant transformation plasmid that is adjusted to a titer of 1.2 X 10 9 bacteria/ml with 4C005K media. Explants are placed into a centrifuge tube, the Agrobacterium suspension is added and the mixture of bacteria and explants is "Vortexed" on maximum setting for 25 seconds to ensure even penetration of bacteria. The bacteria are poured off and the explants are blotted between layers of dry sterile filter paper to remove excess bacteria. The blotted explants are placed upside down on MS104 plates + 2ml 4C005K media + filter disc. Co-culture is 2-3 days. The explants are transferred to MS 104 + Carbenicillin 1000 mg/1 + cefotaxime 100 mg/1 for 3 days (delayed phase). The explants are then transferred to MS104 + glyphosate 0.05 mM + Carbenicillin 1000 mg/1 + cefotaxime 100 mg/1 for selection phase. At 4-6 weeks shoots are cut from callus and placed on MSO + Carbenicillin 500 mg/1 rooting media. Roots form in 3-5 days, at which time leaf pieces can be taken from rooted plates to confirm glyphosate tolerance and that the material is transformed. The presence of the CP4 EPSPS protein in these transformed tissues has been confirmed by immunoblot analysis of leaf discs. The data from one experiment with pMON17227 is presented in the following: 139 shoots formed on glyphosate from 400 explants inoculated with Agrobacterium ABI/pMON17227; 97 of these were positive on recallusing on glyphosate. These data indicate a transformation rate of 24 per 100 explants, which makes this a highly efficient and time saving transformation procedure for plants. Similar transformation frequencies have been obtained with pMON17131 and direct selection of transformants on glyphosate with the CP4 EPSPS genes has also been shown in other plant species, including Arabidopsis, potato, tomato, cotton, lettuce, and sugarbeet. The pMON17227 plasmid contains single restriction enzyme recognition cleavage sites (Notl, Xhol, and BstXI ) between the CP4 glyphosate selection region and the left border of the vector for the cloning of additional genes and to facilitate the introduction of these genes into plants. . EXAMPLE 5 The CP4 EPSPS gene has also been introduced into Black Mexican Sweet (BMS) corn cells with expression of the protein and glyphosate resistance detected in callus. The backbone for this plasmid was a derivative of the high copy plasmid pUC119 (Viera and Messing, 1987). The 1.3Kb Fspl-Dral pUC119 fragment containing the origin of replication was fused to the 1.3Kb Smal-Hindlll filled fragment from pKC7 (Rao and Rogers, 1979) which contains the neomycin phosphotransferase type II gene to confer bacterial kanamycin resistance. This plasmid was used to construct a monocot expression cassette vector containing the 0.6kb cauliflower mosaic virus (CaMV) 35S RNA promoter with a duplication of the -90 to -300 region (Kay et al., 1987), an O.δkb fragment containing an intron from a maize gene in the 5' untranslated leader region, followed by a polylinker and the 3' termination sequences from the nopaline synthase (NOS) gene (Fraley et al., 1983). A 1.7Kb fragment containing the 300bp chloroplast transit peptide from the Arabidopsis EPSP synthase fused in frame to the 1.4Kb coding sequence for the bacterial CP4 EPSP synthase was inserted into the monocot expression cassette in the polylinker between the intron and the NOS termination sequence to form the plasmid pMON19653 (Figure 17). pMON19653 DNA was introduced into Black Mexican Sweet (BMS) cells by co-bombardment with EC9, a plasmid containing a sulfonylurea-resistant form of the maize acetolactate synthase gene. 2.5mg of each plasmid was coated onto tungsten particles and introduced into log-phase BMS cells using a PDS-1000 particle gun essentially as described (Klein et al., 1989). Transformants are selected on MS medium containing 20ppb chlorsulfuron. After initial selection on chlorsulfuron, the calli can be assayed directly by Western blot. Glyphosate tolerance can be assessed by transferring the calli to medium containing 5mM glyphosate. As shown in Table XI, CP4 EPSPS confers glyphosate tolerance to corn callus. To measure CP4 EPSPS expression in corn callus, the following procedure was used: BMS callus (3 g wet weight) was dried on filter paper (Whatman#l) under vacuum, reweighed, and extraction buffer (500 μl/g dry weight; 100 mM Tris, 1 mM EDTA, 10% glycerol) was added. The tissue was homogenized with a Wheaton overhead stirrer for 30 seconds at 2.8 power setting. After centrifugation (3 minutes, Eppendorf microfuge), the supernatant was removed and the protein was quantitated (BioRad Protein Assay). Samples (50 μg/well) were loaded on an SDS PAGE gel (Jule, 3-17%) along with CP4 EPSPS standard (10 ng), electrophoresed, and transferred to nitrocellulose similarly to a previously described method (Padgette, 1987). The nitrocellulose blot was probed with goat anti-CP4 EPSPS IgG, and developed with 1-125 Protein G. The radioactive blot was visualized by autoradiography. Results were quantitated by densitometry on an LKB UltraScan XL laser densitomer and are tabulated below in Table X. Improvements in the expression, of Class I EPSPS could also be achieved by expressing the gene using stronger plant promoters, using better 3' polyadenylation signal sequences, optimizing the sequences around the initiation codon for ribosome loading and translation initiation, or by combination of these or other expression or regulatory sequences or factors. It would also be beneficial to transform the desired plant with a Class I EPSPS gene in conjunction with another glyphosate tolerant EPSPS gene or a gene capable of degrading glyphosate in order to enhance the glyphosate tolerance of the transformed plant. From the foregoing, it will be seen that this invention is one well adapted to attain all the ends and objects hereinabove set forth together with advantages which are obvious and which are inherent to the invention. It will be understood that certain features and subcombinations are of utility and may be employed without reference to other features and subcombinations. This is contemplated by and is within the scope of the claims. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matter herein set forth or shown in the accompanying drawings is to be interpreted as illustrative and not in a limiting sense. EXAMPLE 6 The LBAA Class II EPSPS gene has been introduced into plants and also imparts glyphosate tolerance. Data on tobacco transformed with pMON17206 (infra) are presented in Table XIII. Table Xm ■ Tobacco Glvnhosate Snrav Test .pMON1720fi_ E35S ■ CTP2. B_m EPSPS: 0.4 Ibs ac) Line 7 Psy Rating 33358 9 34586 9 33328 9 34606 9 33377 9 34611 10 34607 10 34601 9 34589 9 Samsum 4 (Control) EIEL_ Q . RAPHY Alton, N.K. and Vapnek, D. (1979) Nature 282:864-869. Ammirato, P.V., et al. Handbook of Plant Cell Culture - Crop Species. Macmillan Publ. Co. (1984). Arnon, D.I. Plant Phvsiol. 24:1-15 (1949). Bachmann, B. J. et al., Microb. Rev.. 44:1-56 (1980). Bartlett, S.G., Grossman, A.R., and Chua, N.H. (1982) in Methods in Chloroplast Molecular Bioloςrv. pp. 1081-1091. M. Edelman, R.B., Hallick, and Chua, N.H.,eds. Bevan, M. (1984) Nucleic Acids Res. 12 (22): 8711-8721. Birnboim, H. C. and Doly, J. (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl. Acids. Res. 7:1513-1525. Boyer, H. W. and Rolland-Dussoix, D. (1969) A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41:459. Christou, P., D. E. McCabe, and W.F. Swain (1988) Stable transformation of Soybean Callus by DNA-Coated Gold Particles. Plant Phvsiol. 87:671-674. Coruzzi, G., Broglie, R., Edwards, C, and Chua, N.H. (1984). Tissue-specific and light-regulated expression of a pea nuclear gene encoding the small subunit of ribulose-l,5-bisphosphate carboxylase. EMBO J 3:1671. della-Cioppa, G., Bauer, S. C, Klein, B. K, Shah, D. M., Fraley, R. T. and Kishore G. K. (1986) Translocation of the precursor of 5-βno/pyruvylshikimate-3-phosphate synthase into chloroplasts of higher plants in vitro. Proc. Natl. Acad Sci. USA 83: 6873-6877. della-Cioppa, G., Bauer, S. C, Taylor, M. T., Rochester, D. E., Klein, B. K, Shah, D. M., Fraley, R. T. and Kishore G. M. (1987) Targeting a herbicide-resistant enzyme from Escherichia coli to chloroplasts of higher plants. Bio/Technology 5: 579-584. Devereux, J., Haeberli, P. and Smithies, 0. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucl. Acids. Res. 12:387-395. Ditta, G., Stanfield, S., Corbin, D., and Helinski, D.R. (1980) Broad host range DNA cloning system for Gram-Negative bacteria: construction of a gene bank of Rhizobium meliloti. Proc Natl Acad Sci USA 77, 7347-7351. Duncan, , Edwards, R.M., Coggins, J.R. (1987) The pentafunctional aroM enzyme of Saccharomyces cerevisiae is a mosaic of monofunctional domains. Biochem. J. 246: 375-386. Dunn, J.J. and Studier, F.W., (1983) J. Mol. Biol. 166:477-535. Fitzgibbon, J. E. (1988) Pseudomonas sp. strain PG2982: uptake of glyphosate and cloning of a gene which confers increased resistance to glyphosate. Ph. D. Dissertation, Louisiana State University. Fitzgibbon, E. F. and Braymer, H. D. (1990) Cloning of a gene from Pseudomonas sp. PG2982 conferring increased glyphosate resistance Appl. Environ. Microbiol. 56: 3382-3388. Fling, M.E., Kopf, J., and Richards, C. (1985). Nucleotide sequence of the transposon Tn7 gene encoding an aroinoglycoside-modifying enzyme, 3"(9)-0 -nucleotidyltransferase. Nucleic Acids Research 13 no.19, 7095-7106. Fraley, R.T., Rogers, S.G., Horsch, R.B., Sanders, P.R. Flick, J.S., Adams, S.P., Bittner, M.L., Brand, L.A., Fink, C.L., Fry, J.S., Galluppi, G.R., Goldberg, S.B., Hoffman, N.L., and Woo, S.C. 1983. Expression of bacterial genes in plant cells. Proc. Natl. Acad. Sci. USA 80:4803-4807. Fraley, R. T., Rogers, S. G., Horsch, R. B., Eichholtz D. A., Flick, J. S., Fink, C. L., Hoffmann, N. L. and Sanders, P. R. (1985) The SEV system: a new disarmed Ti plasmid vector system for plant transformation. Fromm, M., (1990) UCLA Symposium on Molecular Strategies for Crop Improvement, April 16-22, 1990. Keystone, CO. Gasser, C. S., Winter, J. A., Hironaka, C. M. and Shah, D. M. (1988) Structure, expression, and evolution of the 5-enolpyruvylshikimate 3-phosphate synthase genes of petunia and tomato. J. Biol. Chem. 263: 4280-4289. Gowda, S., Wu, F.C., and Shepard, R.J. (1989). Identification of promoter sequences for the major RNA transcripts of figwort mosaic and peanut chlorotic streak viruses (caulimovirus group). Journal of Cellular Biochemistry supplement 13D, 301 (Abstract). Hallas, L. E., Hahn, E. M. and Korndorfer, C. (1988) Characterization of microbial traits associated with glyphosate biodegradation in industrial activated sludge. J. Industrial Microbiol. 3: 377-385. Hayford, M. B., Medford, J. I., Hoffmann, N. L., Rogers, S. G. and Klee, H. J. (1988) Development of a plant transformation selection system based on expression of genes encoding gentamicin acetyltransferases. Plant Physiol. 86: 1216-1222. Herrera-Estrella, L., et al. (1983) Nature 303:209 Horsch, R.B. and H. Klee. (1986) Proc. Natl. Acad. Sri. U.S.A. 83:4428-32. Heitkamp, M. A., Hallas, L. and Adams, W. J. (1990) Biotreatment of industrial wastewater with immobilized microorganisms - Presented in Session 11, Paper S40, Society for Industrial Microbiology Annual Meeting, Orlando, Florida, July 29-August 3, 1990. Hohn, B. and Collins J. (1980) A small cosmid for efficient cloning of large DNA fragments. Gene 11: 291-298. Hunkapiller, M. W., Hewick, R. M., Dreyer, R. J., and Hood, L. (1983) Methods Enzymol. 91, 399-413. Jefferson, R.A., Kavanaugh, T.A. and Bevan, M.W., EMBO J. . 6:3901-3907 (1987). Kay, R., Chan, A., Daly, M. and McPherson, J. 1987. Duplication of the CaMV 35S promoter sequence creates a strong enhancer for plants. Science 236, 1299-1302. Kishore, G., Shah, D., Padgette, S., della-Cioppa, G., Gasser, C, Re, D., Hironaka, C, Taylor, M., Wibbenmeyer, J., Eichholtz, D., Hayford, M., Hoffman, N., Delannay, X., Horsch, R., Klee, H., Rogers, S., Rochester, D., Brundage, L., Sanders, P. and Fraley, R. T. (1988) 5-Enolpyruvylshikimate 3-phosphate synthase: From Biochemistry to genetic engineering of glyphosate tolerance, in Biotechnology for Crop Protection ACS Symposium series No. 379. Eds. Hedlin P. A., Menn, J. J. and Hollingsworth, R. M. pp. 37-48. Kishore, G. and Shah, D. (1988) Ann. Rev. Biochem. 57:627-663. Kishore, G. M., Brundage, L., Kolk, , Padgette, S. R., Rochester, D., Huynh, Q. K. and della-Cioppa, G. (1986) Fed. Proc. 45: 1506. Klee, H.J., et al. (1985) Bio/Technology 3:637-42. Klee, H. J., Muskopf, Y. M. and Gasser, C. S. (1987) Cloning of an Arabidopsis thaliana gene encoding 5-enolpyruvyl-shikimate-3-phosphate synthase: sequence analysis and manipulation to obtain glyphosate tolerant plants. Mol. Gen. Genet. 210: 437-442. Klein, T.M., Kornstein, L., Sanford, J.C., and Fromm, M.E. 1989. Genetic transformation of maize cells by particle bombardment. Plant Phys. 91:440-444. Koncz, C. and Schell, J. (1986) The promoter of TL-DNA gene 5 controls the tissue-specific expression of chimeric genes carried by a novel type of Agrobacterium binary vector. Mol. Gen. Genet. 204:383-396. Kunkel.T. A., Roberts, J. D. and Zakour, R. A. (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367. Laemmli, U.K., "Cleavage of structural proteins during the assembly of the head of the bacteriophage T4" Nature. 227:680 (1970). Maniatis, T., Fritsch, E. F. and Sambrook, J. (1982) Molecular Cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Maskell, D.J., Morrissey, P. and Dougan, G. (1988) Cloning and nucleotide sequence of the aroA gene of Bordetella pertussis. J. Bacteriol. 170:2467-2471. Miller, J. H. (1972). Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Moore, J. K., Braymer, H. D. and Larson, A. D. (1983) Isolation of a Pseudomonas sp. which utilizes the phosphonate herbicide glyphosate. Appl. Environ. Microbiol. 46: 316-320. Morelli, G., Nagy, F., Fraley, R.T., Rogers, S.G., and Chua, N. H. (1985). A short conserved sequence is involved in the light-inducibility of a gene encoding ribulose 1,5-bisphosphate carboxylase small sub unit of pea. Nature 315, 200-204. Odell, J.T., Nagy, F., and Chua, N.H. (1985). Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter. Nature 313, 810-812. Olins, P. O., Devine, C. S., Rangwala, S. H. and Kavka, K. S. (1988) Gene 73: 227-235. Padgette, S. R., Huynh, . K., Borgmeyer, J., Shah, D. M., Brand, L. A, Re, D. B., Bishop, B. F., Rogers, S. G., Fraley, R. T., and Kishore, G. (1987) Bacterial expression and isolation of Petunia hybrida 5-e/ιo/-pyruvylshikimate-3-phosphate synthase. Arch. Biochem. Biophys. 258, 564-573. Padgette, S. R., Huynh, Q. K, Aykent, S., Sammons, R. D., Sikorski, J. A., and Kishore, G. M. (1988) J. Biol. Chem. 263, 1798-1802. Quinn, J. P., Peden, J. M. M. and Dick, E. (1988) Glyphosate tolerance and utilization by the microflora of soils treated with the herbicide. Appl. Microbiol. Biotechnol. 29: 511-516. Rao, R.N. and Rogers, S.G. 1979. Plasmid pKC7: A vector containing ten restriction endonuclease sites suitable for cloning DNA segments. Gene 7:79. Rogers, S.G., Brand, L.A. Holder, S.B. Sharps, E.S. and Brackin, M.J. (1983) Amplification of the aroA gene from E. coli results in tolerance to the herbicide glyphosate. Appl. Environ. Microbiol. 46:37-43. Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1989). Schuler, M. A., Schmitt, E. S. and Beachy, R.N. (1982) Nucleic Acids Res. 10:8225-8244. Schulz, A., Kruper, A. and Amrhein, N. (1985) Differential sensitivity of bacterial 5-enolpyruvylshikimate-3-phosphate synthases to the herbicide glyphosate. FEMS Microbiol. Lett. 28: 297-301. Schulz, A., Sost, D. and Amrhein, D. (1984) Arch. Microbiol. 137: 121-123. Shah, D„ Horsch, R., Klee, H., Kishore, G., Winter, J., Turner, N., Hironaka, C, Sanders, P., Gasser, C, Aykent, S., Siegal, N., Rogers, S., and Fraley, R. (1986). Engineering herbicide tolerance in transgenic plants. Science 233, 478-481. Shimamoto, K. et al. (1989) Nature 338:274-276. Sost, D., Schulz, A. and Amrhein, N. (1984) FEBS Lett. 173: 238-241. Sost, D. and Amrhein, N. (1990) Substitution of Gly-96 to Ala in the 5-enolpyruvylshikimate 3-phosphate synthase of Klebsiella pneumoniae results in greatly reduced affinity for the herbicide glyphosate. Arch. Biochem. Biophys. 282: 433-436. Stalker, D.M., Thomas, CM., and Helinski, D.R. (1981). Nucleotide sequence of the region of the origin of replication of the broad host range plasmid RK2. Mol Gen Genet 181: 8-12. Stalker, D. M., Hiatt, W. R. and Comai, L. (1985) A single amino acid substitution in the enzyme 5-enolpyruvylshikimate 3-phosphate synthase confers resistance to glyphosate. J. Biol. Chem. 260: 4724-4728. Tabor, S. and Richardson, C. C. (1985) A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc. Natl. Acad. Sci. USA 82: 1074-1078. Talbot, H. W., Johnson, L. M. and Munnecke, D. M. (1984) Glyphosate utilization by Pseudomonas sp. and Alcaligenes sp. isolated from environmental sources. Current Microbiol. 10: 255-260. Talmadge, K., and Gilbert, W., "Construction of plasmid vectors with unique PstI cloning sites in the signal sequence coding region" Gene. (12) 235-241 (1980). Vasil, V., F. Redway and I. Vasil., Bio/Technologv 8:429-434 (1990). Velten, J., Velten, R., Hain, R. and Schell, J. (1984) EMBO J. 3:2723-2730. Viera, J. and Messing, J. 1987. Production of single-stranded plasmid DNA. Methods Enzym. 153:3-11. Wibbenmeyer, J., Brundage, L., Padgette, S. R., Likos, J. J., and Kishore, G. M. (1988) Biochem. Biophys. Res. Comm. 153, 760-766. Wong, E. Y., Seetharam, R„ Kotts, C. E., Heeren, R. A., Klein, B. , Braford, S. R., Mathis, K. J., Bishop, B. F., Siegel, N. R., Smith, C. E. and Tacon, W. C. (1988) Expression of excreted insulin-like growth factor-1 in Escherichia coli. Gene 68: 193-203. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Barry, Gerard F. Kishore, Ganesh M. Padgette, Stephen R. (ii) TITLE OF INVENTION: Glyphosate Tolerant 5-Enolpyruvylβhikimate-3-Phosphate Synthases (iii) NUMBER OF SEQUENCES: 36 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Dennis R. Hoerner, Jr., Monsanto Co. BB4F (B) STREET: 700 Chesterfield Village Parkway (C) CITY: St. Louis (D ) STATE : Missouri (E ) COUNTRY : USA (F) ZIP: 63198 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release /l.O, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: US 07/576537 (B) FILING DATE: 31-AUG-1990 (C) CLASSIFICATION: (viii) ATTORNE /AGENT INFORMATION: (A) NAME: Hoerner Jr., Dennis R. (B) REGISTRATION NUMBER: 30,914 (C) REFERENCE/DOCKET NUMBER: 38-21(10535) (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (314)537-6099 (B) TELEFAX: (314)537-6047 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 597 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID N0:1: TCATCAAAAT ATTTAGCAGC ATTCCAGATT GGGTTCAATC AACAAGGTAC GAGCCATATC 60 ACTTTATTCA AATTGGTATC GCCAAAACCA AGAAGGAACT CCCATCCTCA AAGGTTTGTA 120 AGGAAGAATT CTCAGTCCAA AGCCTCAACA AGGTCAGGGT ACAGAGTCTC CAAACCATTA 180 GCCAAAAGCT ACAGGAGATC AATGAAGAAT CTTCAATCAA AGTAAACTAC TGTTCCAGCA 240 CATGCATCAT GGTCAGTAAG TTTCAGAAAA AGACATCCAC CGAAGACTTA AAGTTAGTGG 300 GCATCTTTGA AAGTAATCTT GTCAACATCG AGCAGCTGGC TTGTGGGGAC CAGACAAAAA 360 AGGAATGGTG CAGAATTGTT AGGCGCACCT ACCAAAAGCA TCTTTGCCTT TATTGCAAAG 420 , ATAAAGCAGA TTCCTCTAGT ACAAGTGGGG AACAAAATAA CGTGGAAAAG AGCTGTCCTG 480 ACAGCCCACT CACTAATGCG TATGACGAAC GCAGTGACGA CCACAAAAGA ATTCCCTCTA 540 TATAAGAAGG CATTCATTCC CATTTGAAGG ATCATCAGAT ACTAACCAAT ATTTCTC 597 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1982 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 62..1426 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: AAGCCCGCGT TCTCTCCGGC GCTCCGCCCG GAGAGCCGTG GATAGATTAA GGAAGACGCC 60 C ATG TCG CAC GGT GCA AGC AGC CGG CCC GCA ACC GCC CGC AAA TCC 106 Met Ser His Gly Ala Ser Ser Arg Pro Ala Thr Ala Arg Lys Ser 1 5 10 15 TCT GGC CTT TCC GGA ACC GTC CGC ATT CCC GGC GAC AAG TCG ATC TCC 154 Ser Gly Leu Ser Gly Thr Val Arg lie Pro Gly Asp Lys Ser lie Ser 20 25 30 CAC CGG TCC TTC ATG TTC GGC GGT CTC GCG AGC GGT GAA ACG CGC ATC 202 His Arg Ser Phe Met Phe Gly Gly Leu Ala Ser Gly Glu Thr Arg lie 35 40 45 ACC GGC CTT CTG GAA GGC GAG GAC GTC ATC AAT ACG GGC AAG GCC ATG 250 Thr Gly Leu Leu Glu Gly Glu Asp Val He Asn Thr Gly Lys Ala Met 50 55 60 CAG GCC ATG GGC GCC AGG ATC CGT AAG GAA GGC GAC ACC TGG ATC ATC 298 Gin Ala Met Gly Ala Arg He Arg Lys Glu Gly Asp Thr Trp He He 65 70 75 GAT GGC GTC GGC AAT GGC GGC CTC CTG GCG CCT GAG GCG CCG CTC GAT 346 Asp Gly Val Gly Asn Gly Gly Leu Leu Ala Pro Glu Ala Pro Leu Asp 80 85 90 95 TTC GGC AAT GCC GCC ACG GGC TGC CGC CTG ACC ATG GGC CTC GTC GGG 394 Phe Gly Asn Ala Ala Thr Gly Cys Arg Leu Thr Met Gly Leu Val Gly 100 105 110 GTC TAC GAT TTC GAC AGC ACC TTC ATC GGC GAC GCC TCG CTC ACA AAG 442 Val Tyr Asp Phe Asp Ser Thr Phe He Gly Asp Ala Ser Leu Thr Lys 115 120 125 CGC CCG ATG GGC CGC GTG TTG AAC CCG CTG CGC GAA ATG GGC GTG CAG 490 Arg Pro Met Gly Arg Val Leu Asn Pro Leu Arg Glu Met Gly Val Gin 130 135 140 GTG AAA TCG GAA GAC GGT GAC CGT CTT CCC GTT ACC TTG CGC GGG CCG 538 Val Lys Ser Glu Asp Gly Asp Arg Leu Pro Val Thr Leu Arg Gly Pro 145 150 155 AAG ACG CCG ACG CCG ATC ACC TAC CGC GTG CCG ATG GCC TCC GCA CAG 586 Lys Thr Pro Thr Pro He Thr Tyr Arg Val Pro Met Ala Ser Ala Gin 160 165 170 175 GTG AAG TCC GCC GTG CTG CTC GCC GGC CTC AAC ACG CCC GGC ATC ACG 634 Val Lys Ser Ala Val Leu Leu Ala Gly Leu Asn Thr Pro Gly He Thr 180 185 190 ACG GTC ATC GAG CCG ATC ATG ACG CGC GAT CAT ACG GAA AAG ATG CTG 682 Thr Val He Glu Pro He Met Thr Arg Asp His Thr Glu Lys Met Leu 195 200 205 CAG GGC TTT GGC GCC AAC CTT ACC GTC GAG ACG GAT GCG GAC GGC GTG 730 Gin Gly Phe Gly Ala Asn Leu Thr Val Glu Thr Asp Ala Asp Gly Val 210 215 220 CGC ACC ATC CGC CTG GAA GGC CGC GGC AAG CTC ACC GGC CAA GTC ATC 778 Arg Thr He Arg Leu Glu Gly Arg Gly Lys Leu Thr Gly Gin Val He 225 230 235 GAC GTG CCG GGC GAC CCG TCC TCG ACG GCC TTC CCG CTG GTT GCG GCC 826 Asp Val Pro Gly Asp Pro Ser Ser Thr Ala Phe Pro Leu Val Ala Ala 240 245 250 255 CTG CTT GTT CCG GGC TCC GAC GTC ACC ATC CTC AAC GTG CTG ATG AAC 874 Leu Leu Val Pro Gly Ser Asp Val Thr He Leu Asn Val Leu Met Asn 260 265 270 CCC ACC CGC ACC GGC CTC ATC CTG ACG CTG CAG GAA ATG GGC GCC GAC 922 Pro Thr Arg Thr Gly Leu He Leu Thr Leu Gin Glu Met Gly Ala Aβp 275 280 285 ATC GAA GTC ATC AAC CCG CGC CTT GCC GGC GGC GAA GAC GTG GCG GAC 970 He Glu Val He Asn Pro Arg Leu Ala Gly Gly Glu Asp Val Ala Asp 290 295 300 CTG CGC GTT CGC TCC TCC ACG CTG AAG GGC GTC ACG GTG CCG GAA GAC 1018 Leu Arg Val Arg Ser Ser Thr Leu Lys Gly Val Thr Val Pro Glu Asp 305 310 315 CGC GCG CCT TCG ATG ATC GAC GAA TAT CCG ATT CTC GCT GTC GCC GCC 1066 Arg Ala Pro Ser Met He Asp Glu Tyr Pro He Leu Ala Val Ala Ala 320 325 330 335 GCC TTC GCG GAA GGG GCG ACC GTG ATG AAC GGT CTG GAA GAA CTC CGC 1114 Ala Phe Ala Glu Gly Ala Thr Val Met Asn Gly Leu Glu Glu Leu Arg 340 345 350 GTC AAG GAA AGC GAC CGC CTC TCG GCC GTC GCC AAT GGC CTC AAG CTC 1162 Val Lys Glu Ser Asp Arg Leu Ser Ala Val Ala Asn Gly Leu Lys Leu 355 360 365 AAT GGC GTG GAT TGC GAT GAG GGC GAG ACG TCG CTC GTC GTG CGC GGC 1210 Asn Gly Val Asp Cys Aβp Glu Gly Glu Thr Ser Leu Val Val Arg Gly 370 375 380 CGC CCT GAC GGC AAG GGG CTC GGC AAC GCC TCG GGC GCC GCC GTC GCC 1258 Arg Pro Asp Gly Lys Gly Leu Gly Asn Ala Ser Gly Ala Ala Val Ala 385 390 395 ACC CAT CTC GAT CAC CGC ATC GCC ATG AGC TTC CTC GTC ATG GGC CTC 1306 Thr His Leu Asp His Arg He Ala Met Ser Phe Leu Val Met Gly Leu 400 405 410 415 GTG TCG GAA AAC CCT GTC ACG GTG GAC GAT GCC ACG ATG ATC GCC ACG 1354 Val Ser Glu Asn Pro Val Thr Val Asp Asp Ala Thr Met He Ala Thr 420 425 430 AGC TTC CCG GAG TTC ATG GAC CTG ATG GCC GGG CTG GGC GCG AAG ATC 1402 Ser Phe Pro Glu Phe Met Asp Leu Met Ala Gly Leu Gly Ala Lys He 435 440 445 GAA CTC TCC GAT ACG AAG GCT GCC TGATGACCTT CACAATCGCC ATCGATGGTC 1456 Glu Leu Ser Asp Thr Lys Ala Ala 450 455 CCGCTGCGGC CGGCAAGGGG ACGCTCTCGC GCCGTATCGC GGAGGTCTAT GGCTTTCATC 1516 ATCTCGATAC GGGCCTGACC TATCGCGCCA CGGCCAAAGC GCTGCTCGAT CGCGGCCTGT 1576 CGCTTGATGA CGAGGCGGTT GCGGCCGATG TCGCCCGCAA TCTCGATCTT GCCGGGCTCG 1636 ACCGGTCGGT GCTGTCGGCC CATGCCATCG GCGAGGCGGC TTCGAAGATC GCGGTCATGC 1696 CCTCGGTGCG GCGGGCGCTG GTCGAGGCGC AGCGCAGCTT TGCGGCGCGT GAGCCGGGCA 1756 CGGTGCTGGA TGGACGCGAT ATCGGCACGG TGGTCTGCCC GGATGCGCCG GTGAAGCTCT 1816 ATGTCACCGC GTCACCGGAA GTGCGCGCGA AACGCCGCTA TGACGAAATC CTCGGCAATG 1876 GCGGGTTGGC CGATTACGGG ACGATCCTCG AGGATATCCG CCGCCGCGAC GAGCGGGACA 1936 TGGGTCGGGC GGACAGTCCT TTGAAGCCCG CCGACGATGC GCACTT 1982 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 455 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: Met Ser His Gly Ala Ser Ser Arg Pro Ala Thr Ala Arg Lys Ser Ser 1 5 10 15 Gly Leu Ser Gly Thr Val Arg He Pro Gly Asp Lys Ser He Ser His 20 25 30 Arg Ser Phe Met Phe Gly Gly Leu Ala Ser Gly Glu Thr Arg He Thr 35 40 45 Gly Leu Leu Glu Gly Glu Asp Val He Asn Thr Gly Lys Ala Met Gin 50 55 60 Ala Met Gly Ala Arg He Arg Lys Glu Gly Asp Thr Trp He He Asp 65 70 75 80 Gly Val Gly Asn Gly Gly Leu Leu Ala Pro Glu Ala Pro Leu Asp Phe 85 90 95 Gly Asn Ala Ala Thr Gly Cys Arg Leu Thr Met Gly Leu Val Gly Val 100 105 110 Tyr Asp Phe Aεp Ser Thr Phe He Gly Asp Ala Ser Leu Thr Lys Arg 115 120 125 Pro Met Gly Arg Val Leu Asn Pro Leu Arg Glu Met Gly Val Gin Val 130 135 140 Lys Ser Glu Asp Gly Asp Arg Leu Pro Val Thr Leu Arg Gly Pro Lys 145 150 155 160 Thr Pro Thr Pro He Thr Tyr Arg Val Pro Met Ala Ser Ala Gin Val 165 170 175 Lys Ser Ala Val Leu Leu Ala Gly Leu Asn Thr Pro Gly He Thr Thr 180 185 190 Val He Glu Pro He Met Thr Arg Aβp His Thr Glu Lye Met Leu Gin 195 200 205 Gly Phe Gly Ala Asn Leu Thr Val Glu Thr Aβp Ala Aβp Gly Val Arg 210 215 220 Thr He Arg Leu Glu Gly Arg Gly Lys Leu Thr Gly Gin Val He Asp 225 230 235 240 Val Pro Gly Asp Pro Ser Ser Thr Ala Phe Pro Leu Val Ala Ala Leu 245 250 255 Leu Val Pro Gly Ser Asp Val Thr He Leu Asn Val Leu Met Asn Pro 260 265 270 Thr Arg Thr Gly Leu He Leu Thr Leu Gin Glu Met Gly Ala Asp He 275 280 285 Glu Val He Asn Pro Arg Leu Ala Gly Gly Glu Asp Val Ala Asp Leu 290 295 300 Arg Val Arg Ser Ser Thr Leu Lye Gly Val Thr Val Pro Glu Aβp Arg 305 310 315 320 Ala Pro Ser Met He Asp Glu Tyr Pro He Leu Ala Val Ala Ala Ala 325 330 335 Phe Ala Glu Gly Ala Thr Val Met Asn Gly Leu Glu Glu Leu Arg Val 340 345 350 Lys Glu Ser Asp Arg Leu Ser Ala Val Ala Asn Gly Leu Lys Leu Asn 355 360 365 Gly Val Asp Cys Asp Glu Gly Glu Thr Ser Leu Val Val Arg Gly Arg 370 375 380 Pro Asp Gly Lye Gly Leu Gly Asn Ala Ser Gly Ala Ala Val Ala Thr 385 390 395 400 His Leu Asp His Arg He Ala Met Ser Phe Leu Val Met Gly Leu Val 405 410 415 Ser Glu Asn Pro Val Thr Val Asp Asp Ala Thr Met He Ala Thr Ser 420 425 430 Phe Pro Glu Phe Met Asp Leu Met Ala Gly Leu Gly Ala Lys He Glu 435 440 445 Leu Ser Asp Thr Lys Ala Ala 450 455 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1673 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 86..1432 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: GTAGCCACAC ATAATTACTA TAGCTAGGAA GCCCGCTATC TCTCAATCCC GCGTGATCGC 60 GCCAAAATGT GACTGTGAAA AATCC ATG TCC CAT TCT GCA TCC CCG AAA CCA 112 Met Ser His Ser Ala Ser Pro Lys Pro 1 5 GCA ACC GCC CGC CGC TCG GAG GCA CTC ACG GGC GAA ATC CGC ATT CCG 160 Ala Thr Ala Arg Arg Ser Glu Ala Leu Thr Gly Glu He Arg He Pro 10 15 20 25 GGC GAC AAG TCC ATC TCG CAT CGC TCC TTC ATG TTT GGC GGT CTC GCA 208 Gly Asp Lys Ser He Ser His Arg Ser Phe Met Phe Gly Gly Leu Ala 30 35 40 TCG GGC GAA ACC CGC ATC ACC GGC CTT CTG GAA GGC GAG GAC GTC ATC 256 Ser Gly Glu Thr Arg He Thr Gly Leu Leu Glu Gly Glu Asp Val He 45 50 55 AAT ACA GGC CGC GCC ATG CAG GCC ATG GGC GCG AAA ATC CGT AAA GAG 304 Asn Thr Gly Arg Ala Met Gin Ala Met Gly Ala Lys He Arg Lys Glu 60 65 70 GGC GAT GTC TGG ATC ATC AAC GGC GTC GGC AAT GGC TGC CTG TTG CAG 352 Gly Asp Val Trp He He Asn Gly Val Gly Asn Gly Cys Leu Leu Gin 75 80 85 CCC GAA GCT GCG CTC GAT TTC GGC AAT GCC GGA ACC GGC GCG CGC CTC 400 Pro Glu Ala Ala Leu Asp Phe Gly Asn Ala Gly Thr Gly Ala Arg Leu 90 95 100 105 ACC ATG GGC CTT GTC GGC ACC TAT GAC ATG AAG ACC TCC TTT ATC GGC 448 Thr Met Gly Leu Val Gly Thr Tyr Asp Met Lys Thr Ser Phe He Gly 110 115 120 GAC GCC TCG CTG TCG AAG CGC CCG ATG GGC CGC GTG CTG AAC CCG TTG 496 Asp Ala Ser Leu Ser Lys Arg Pro Met Gly Arg Val Leu Asn Pro Leu 125 130 135 CGC GAA ATG GGC GTT CAG GTG GAA GCA GCC GAT GGC GAC CGC ATG CCG 544 Arg Glu Met Gly Val Gin Val Glu Ala Ala Asp Gly Asp Arg Met Pro 140 145 150 CTG ACG CTG ATC GGC CCG AAG ACG GCC AAT CCG ATC ACC TAT CGC GTG 592 Leu Thr Leu He Gly Pro Lys Thr Ala Asn Pro He Thr Tyr Arg Val 155 160 165 CCG ATG GCC TCC GCG CAG GTA AAA TCC GCC GTG CTG CTC GCC GGT CTC 640 Pro Met Ala Ser Ala Gin Val Lys Ser Ala Val Leu Leu Ala Gly Leu 170 175 180 185 AAC ACG CCG GGC GTC ACC ACC GTC ATC GAG CCG GTC ATG ACC CGC GAC 688 Asn Thr Pro Gly Val Thr Thr Val He Glu Pro Val Met Thr Arg Asp 190 ' 195 200 CAC ACC GAA AAG ATG CTG CAG GGC TTT GGC GCC GAC CTC ACG GTC GAG 736 His Thr Glu Lys Met Leu Gin Gly Phe Gly Ala Asp Leu Thr Val Glu 205 210 215 ACC GAC AAG GAT GGC GTG CGC CAT ATC CGC ATC ACC GGC CAG GGC AAG 784 Thr Asp Lys Asp Gly Val Arg His He Arg He Thr Gly Gin Gly Lye 220 225 230 CTT GTC GGC CAG ACC ATC GAC GTG CCG GGC GAT CCG TCA TCG ACC GCC 832 Leu Val Gly Gin Thr He Asp Val Pro Gly Asp Pro Ser Ser Thr Ala 235 240 245 TTC CCG CTC GTT GCC GCC CTT CTG GTG GAA GGT TCC GAC GTC ACC ATC 880 Phe Pro Leu Val Ala Ala Leu Leu Val Glu Gly Ser Asp Val Thr He 250 255 260 265 CGC AAC GTG CTG ATG AAC CCG ACC CGT ACC GGC CTC ATC CTC ACC TTG 928 Arg Asn Val Leu Met Asn Pro Thr Arg Thr Gly Leu He Leu Thr Leu 270 275 280 CAG GAA ATG GGC GCC GAT ATC GAA GTG CTC AAT GCC CGT CTT GCA GGC 976 Gin Glu Met Gly Ala Asp He Glu Val Leu Asn Ala Arg Leu Ala Gly 285 290 295 GGC GAA GAC GTC GCC GAT CTG CGC GTC AGG GCT TCG AAG CTC AAG GGC 1024 Gly Glu Asp Val Ala Aβp Leu Arg Val Arg Ala Ser Lye Leu Lys Gly 300 305 310 GTC GTC GTT CCG CCG GAA CGT GCG CCG TCG ATG ATC GAC GAA TAT CCG 1072 Val Val Val Pro Pro Glu Arg Ala Pro Ser Met He Asp Glu Tyr Pro 315 320 325 GTC CTG GCG ATT GCC GCC TCC TTC GCG GAA GGC GAA ACC GTG ATG GAC 1120 Val Leu Ala He Ala Ala Ser Phe Ala Glu Gly Glu Thr Val Met Asp 330 335 340 345 GGG CTC GAC GAA CTG CGC GTC AAG GAA TCG GAT CGT CTG GCA GCG GTC 1168 Gly Leu Asp Glu Leu Arg Val Lys Glu Ser Asp Arg Leu Ala Ala Val 350 355 360 GCA CGC GGC CTT GAA GCC AAC GGC GTC GAT TGC ACC GAA GGC GAG ATG 1216 Ala Arg Gly Leu Glu Ala Asn Gly Val Aβp Cyβ Thr Glu Gly Glu Met 365 370 375 TCG CTG ACG GTT CGC GGC CGC CCC GAC GGC AAG GGA CTG GGC GGC GGC 1264 Ser Leu Thr Val Arg Gly Arg Pro Aβp Gly Lye Gly Leu Gly Gly Gly 380 385 390 ACG GTT GCA ACC CAT CTC GAT CAT CGT ATC GCG ATG AGC TTC CTC GTG 1312 Thr Val Ala Thr Hie Leu Aβp Hie Arg He Ala Met Ser Phe Leu Val 395 400 405 ATG GGC CTT GCG GCG GAA AAG CCG GTG ACG GTT GAC GAC AGT AAC ATG 1360 Met Gly Leu Ala Ala Glu Lye Pro Val Thr Val Aβp Asp Ser Aβn Met 410 415 420 425 ATC GCC ACG TCC TTC CCC GAA TTC ATG GAC ATG ATG CCG GGA TTG GGC 1408 He Ala Thr Ser Phe Pro Glu Phe Met Asp Met Met Pro Gly Leu Gly 430 435 440 GCA AAG ATC GAG TTG AGC ATA CTC TAGTCACTCG ACAGCGAAAA TATTATTTGC 1462 Ala Lys He Glu Leu Ser He Leu 445 GAGATTGGGC ATTATTACCG GTTGGTCTCA GCGGGGGTTT AATGTCCAAT CTTCCATACG 1522 TAACAGCATC AGGAAATATC AAAAAAGCTT TAGAAGGAAT TGCTAGAGCA GCGACGCCGC 1582 CTAAGCTTTC TCAAGACTTC GTTAAAACTG TACTGAAATC CCGGGGGGTC CGGGGATCAA 1642 ATGACTTCAT TTCTGAGAAA TTGGCCTCGC A 1673 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 449 amino acidβ (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Met Ser Hie Ser Ala Ser Pro Lys Pro Ala Thr Ala Arg Arg Ser Glu 1 5 10 15 Ala Leu Thr Gly Glu He Arg He Pro Gly Asp Lys Ser He Ser His 20 . 25 30 Arg Ser Phe Met Phe Gly Gly Leu Ala Ser Gly Glu Thr Arg He Thr 35 40 45 Gly Leu Leu Glu Gly Glu Asp Val He Asn Thr Gly Arg Ala Met Gin 50 55 60 Ala Met Gly Ala Lys He Arg Lye Glu Gly Aβp Val Trp He He Aβn 65 70 75 80 Gly Val Gly Asn Gly Cys Leu Leu Gin Pro Glu Ala Ala Leu Asp Phe 85 90 95 Gly Aβn Ala Gly Thr Gly Ala Arg Leu Thr Met Gly Leu Val Gly Thr 100 105 110 Tyr Asp Met Lye Thr Ser Phe He Gly Asp Ala Ser Leu Ser Lys Arg 115 120 125 Pro Met Gly Arg Val Leu Asn Pro Leu Arg Glu Met Gly Val Gin Val 130 135 140 Glu Ala Ala Asp Gly Asp Arg Met Pro Leu Thr Leu He Gly Pro Lys 145 150 155 160 Thr Ala Asn Pro He Thr Tyr Arg Val Pro Met Ala Ser Ala Gin Val 165 170 175 Lys Ser Ala Val Leu Leu Ala Gly Leu Asn Thr Pro Gly Val Thr Thr 180 185 190 Val He Glu Pro Val Met Thr Arg Asp Hie Thr Glu Lys Met Leu Gin 195 200 205 Gly Phe Gly Ala Asp Leu Thr Val Glu Thr Asp Lys Asp Gly Val Arg 210 215 220 Hie He Arg He Thr Gly Gin Gly Lys Leu Val Gly Gin Thr He Asp 225 230 235 240 Val Pro Gly Aβp Pro Ser Ser Thr Ala Phe Pro Leu Val Ala Ala Leu 245 250 255 Leu Val Glu Gly Ser Asp Val Thr He Arg Asn Val Leu Met Asn Pro 260 265 270 Thr Arg Thr Gly Leu He Leu Thr Leu Gin Glu Met Gly Ala Asp He 275 280 285 Glu Val Leu Asn Ala Arg Leu Ala Gly Gly Glu Asp Val Ala Asp Leu 290 295 300 Arg Val Arg Ala Ser Lyβ Leu Lye Gly Val Val Val Pro Pro Glu Arg 305 310 315 320 Ala Pro Ser Met He Asp Glu Tyr Pro Val Leu Ala He Ala Ala Ser 325 330 335 Phe Ala Glu Gly Glu Thr Val Met Asp Gly Leu Asp Glu Leu Arg Val 340 345 350 Lyβ Glu Ser Aβp Arg Leu Ala Ala Val Ala Arg Gly Leu Glu Ala Asn 355 360 365 Gly Val Aβp Cyβ Thr Glu Gly Glu Met Ser Leu Thr Val Arg Gly Arg 370 375 380 Pro Asp Gly Lyβ Gly Leu Gly Gly Gly Thr Val Ala Thr His Leu Aβp 385 390 395 400 Hiβ Arg He Ala Met Ser Phe Leu Val Met Gly Leu Ala Ala Glu Lyβ 405 410 415 Pro Val Thr Val Asp Asp Ser Asn Met He Ala Thr Ser Phe Pro Glu 420 425 430 Phe Met Asp Met Met Pro Gly Leu Gly Ala Lys He Glu Leu Ser He 435 440 445 Leu (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1500 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 34..1380 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: GTGATCGCGC CAAAATGTGA CTGTGAAAAA TCC ATG TCC CAT TCT GCA TCC CCG 54 Met Ser His Ser Ala Ser Pro 1 5 AAA CCA GCA ACC GCC CGC CGC TCG GAG GCA CTC ACG GGC GAA ATC CGC 102 Lys Pro Ala Thr Ala Arg Arg Ser Glu Ala Leu Thr Gly Glu He Arg 10 15 20 ATT CCG GGC GAC AAG TCC ATC TCG CAT CGC TCC TTC ATG TTT GGC GGT 150 He Pro Gly Asp Lys Ser He Ser His Arg Ser Phe Met Phe Gly Gly 25 30 35 CTC GCA TCG GGC GAA ACC CGC ATC ACC GGC CTT CTG GAA GGC GAG GAC 198 Leu Ala Ser Gly Glu Thr Arg He Thr Gly Leu Leu Glu Gly Glu Asp 40 45 50 55 GTC ATC AAT ACA GGC CGC GCC ATG CAG GCC ATG GGC GCG AAA ATC CGT 246 Val He Asn Thr Gly Arg Ala Met Gin Ala Met Gly Ala Lys He Arg 60 65 70 AAA GAG GGC GAT GTC TGG ATC ATC AAC GGC GTC GGC AAT GGC TGC CTG 294 Lys Glu Gly Aβp Val Trp He He Aβn Gly Val Gly Asn Gly Cys Leu 75 80 85 TTG CAG CCC GAA GCT GCG CTC GAT TTC GGC AAT GCC GGA ACC GGC GCG 342 Leu Gin Pro Glu Ala Ala Leu Asp Phe Gly Asn Ala Gly Thr Gly Ala 90 95 100 , CGC CTC ACC ATG GGC CTT GTC GGC ACC TAT GAC ATG AAG ACC TCC TTT 390 Arg Leu Thr Met Gly Leu Val Gly Thr Tyr Aβp Met Lys Thr Ser Phe 105 110 115 ATC GGC GAC GCC TCG CTG TCG AAG CGC CCG ATG GGC CGC GTG CTG AAC 438 He Gly Asp Ala Ser Leu Ser Lys Arg Pro Met Gly Arg Val Leu Asn 120 125 130 135 CCG TTG CGC GAA ATG GGC GTT CAG GTG GAA GCA GCC GAT GGC GAC CGC 486 Pro Leu Arg Glu Met Gly Val Gin Val Glu Ala Ala Asp Gly Asp Arg 140 145 150 ATG CCG CTG ACG CTG ATC GGC CCG AAG ACG GCC AAT CCG ATC ACC TAT 534 Met Pro Leu Thr Leu He Gly Pro Lys Thr Ala Asn Pro He Thr Tyr 155 160 165 CGC GTG CCG ATG GCC TCC GCG CAG GTA AAA TCC GCC GTG CTG CTC GCC 582 Arg Val Pro Met Ala Ser Ala Gin Val Lys Ser Ala Val Leu Leu Ala 170 175 180 GGT CTC AAC ACG CCG GGC GTC ACC ACC GTC ATC GAG CCG GTC ATG ACC 630 Gly Leu Asn Thr Pro Gly Val Thr Thr Val He Glu Pro Val Met Thr 185 190 195 CGC GAC CAC ACC GAA AAG ATG CTG CAG GGC TTT GGC GCC GAC CTC ACG 678 Arg Asp His Thr Glu Lys Met Leu Gin Gly Phe Gly Ala Asp Leu Thr 200 205 210 215 GTC GAG ACC GAC AAG GAT GGC GTG CGC CAT ATC CGC ATC ACC GGC CAG 726 Val Glu Thr Asp Lys Asp Gly Val Arg His He Arg He Thr Gly Gin 220 225 230 GGC AAG CTT GTC GGC CAG ACC ATC GAC GTG CCG GGC GAT CCG TCA TCG 774 Gly Lys Leu Val Gly Gin Thr He Asp Val Pro Gly Asp Pro Ser Ser 235 240 245 ACC GCC TTC CCG CTC GTT GCC GCC CTT CTG GTG GAA GGT TCC GAC GTC 822 Thr Ala Phe Pro Leu Val Ala Ala Leu Leu Val Glu Gly Ser Asp Val 250 255 260 ACC ATC CGC AAC GTG CTG ATG AAC CCG ACC CGT ACC GGC CTC ATC CTC 870 Thr He Arg Asn Val Leu Met Asn Pro Thr Arg Thr Gly Leu He Leu 265 270 275 ACC TTG CAG GAA ATG GGC GCC GAT ATC GAA GTG CTC AAT GCC CGT CTT 918 Thr Leu Gin Glu Met Gly Ala Asp He Glu Val Leu Asn Ala Arg Leu 280 285 290 295 GCA GGC GGC GAA GAC GTC GCC GAT CTG CGC GTC AGG GCT TCG AAG CTC 966 Ala Gly Gly Glu Asp Val Ala Asp Leu Arg Val Arg Ala Ser Lyβ Leu 300 305 310 AAG GGC GTC GTC GTT CCG CCG GAA CGT GCG CCG TCG ATG ATC GAC GAA 1014 Lyβ Gly Val Val Val Pro Pro Glu Arg Ala Pro Ser Met He Asp Glu 315 320 325 TAT CCG GTC CTG GCG ATT GCC GCC TCC TTC GCG GAA GGC GAA ACC GTG 1062 Tyr Pro Val Leu Ala He Ala Ala Ser Phe Ala Glu Gly Glu Thr Val 330 335 340 ATG GAC GGG CTC GAC GAA CTG CGC GTC AAG GAA TCG GAT CGT CTG GCA 1110 Met Asp Gly Leu Asp Glu Leu Arg Val Lys Glu Ser Asp Arg Leu Ala 345 350 355 GCG GTC GCA CGC GGC CTT GAA GCC AAC GGC GTC GAT TGC ACC GAA GGC 1158 Ala Val Ala Arg Gly Leu Glu Ala Asn Gly Val Aβp Cyβ Thr Glu Gly 360 365 370 375 GAG ATG TCG CTG ACG GTT CGC GGC CGC CCC GAC GGC AAG GGA CTG GGC 1206 Glu Met Ser Leu Thr Val Arg Gly Arg Pro Asp Gly Lys Gly Leu Gly 380 385 390 GGC GGC ACG GTT GCA ACC CAT CTC GAT CAT CGT ATC GCG ATG AGC TTC 1254 Gly Gly Thr Val Ala Thr His Leu Aβp His Arg He Ala Met Ser Phe 395 400 405 CTC GTG ATG GGC CTT GCG GCG GAA AAG CCG GTG ACG GTT GAC GAC AGT 1302 Leu Val Met Gly Leu Ala Ala Glu Lys Pro Val Thr Val Asp Asp Ser 410 415 420 AAC ATG ATC GCC ACG TCC TTC CCC GAA TTC ATG GAC ATG ATG CCG GGA 1350 Asn Met He Ala Thr Ser Phe Pro Glu Phe Met Asp Met Met Pro Gly 425 430 435 TTG GGC GCA AAG ATC GAG TTG AGC ATA CTC TAGTCACTCG ACAGCGAAAA 1400 Leu Gly Ala Lys He Glu Leu Ser He Leu 440 445 TATTATTTGC GAGATTGGGC ATTATTACCG GTTGGTCTCA GCGGGGGTTT AATGTCCAAT 1460 CTTCCATACG TAACAGCATC AGGAAATATC AAAAAAGCTT 1500 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 449 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: Met Ser His Ser Ala Ser Pro Lys Pro Ala Thr Ala Arg Arg Ser Glu 1 5 10 15 Ala Leu Thr Gly Glu He Arg He Pro Gly Asp Lys Ser He Ser His 20 25 30 Arg Ser Phe Met Phe Gly Gly Leu Ala Ser Gly Glu Thr Arg He Thr 35 40 45 Gly Leu Leu Glu Gly Glu Asp Val He λβn Thr Gly Arg Ala Met Gin 50 55 60 Ala Met Gly Ala Lys He Arg Lyβ Glu Gly Aβp Val Trp He He Aβn 65 70 75 80 Gly Val Gly Aβn Gly Cyβ Leu Leu Gin Pro Glu Ala Ala Leu Asp Phe 85 90 95 Gly Asn Ala Gly Thr Gly Ala Arg Leu Thr Met Gly Leu Val Gly Thr 100 105 110 Tyr Asp Met Lys Thr Ser Phe He Gly Asp Ala Ser Leu Ser Lys Arg 115 120 125 Pro Met Gly Arg Val Leu Asn Pro Leu Arg Glu Met Gly Val Gin Val 130 135 140 Glu Ala Ala Asp Gly Asp Arg Met Pro Leu Thr Leu He Gly Pro Lys 145 150 155 160 Thr Ala Asn Pro He Thr Tyr Arg Val Pro Met Ala Ser Ala Gin Val 165 170 175 Lys Ser Ala Val Leu Leu Ala Gly Leu Asn Thr Pro Gly Val Thr Thr 180 185 190 Val He Glu Pro Val Met Thr Arg Asp His Thr Glu Lyβ Met Leu Gin 195 200 205 Gly Phe Gly Ala Asp Leu Thr Val Glu Thr Asp Lys Asp Gly Val Arg 210 215 220 His He Arg He Thr Gly Gin Gly Lys Leu Val Gly Gin Thr He Asp 225 230 235 240 Val Pro Gly Aβp Pro Ser Ser Thr Ala Phe Pro Leu Val Ala Ala Leu 245 250 255 Leu Val Glu Gly Ser Aβp Val Thr He Arg Aβn Val Leu Met Aβn Pro 260 265 270 Thr Arg Thr Gly Leu He Leu Thr Leu Gin Glu Met Gly Ala Asp He 275 280 285 Glu Val Leu Asn Ala Arg Leu Ala Gly Gly Glu Asp Val Ala Asp Leu 290 295 300 Arg Val Arg Ala Ser Lyβ Leu Lyβ Gly Val Val Val Pro Pro Glu Arg 305 310 315 320 Ala Pro Ser Met He Aβp Glu Tyr Pro Val Leu Ala He Ala Ala Ser 325 330 335 Phe Ala Glu Gly Glu Thr Val Met Asp Gly Leu Asp Glu Leu Arg Val 340 345 350 Lyβ Glu Ser Asp Arg Leu Ala Ala Val Ala Arg Gly Leu Glu Ala Aβn 355 360 365 Gly Val Aβp Cyβ Thr Glu Gly Glu Met Ser Leu Thr Val Arg Gly Arg 370 375 380 Pro Asp Gly Lys Gly Leu Gly Gly Gly Thr Val Ala Thr His Leu Asp 385 390 395 400 His Arg He Ala Met Ser Phe Leu Val Met Gly Leu Ala Ala Glu Lyβ 405 410 415 Pro Val Thr Val Asp Asp Ser Asn Met He Ala Thr Ser Phe Pro Glu 420 425 430 Phe Met Asp Met Met Pro Gly Leu Gly Ala Lys He Glu Leu Ser He 435 440 445 Leu (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 423 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: Ser Leu Thr Leu Gin Pro He Ala Arg Val Asp Gly Thr He Asn Leu 1 5 10 15 Pro Gly Ser Lys Thr Val Ser Asn Arg Ala Leu Leu Leu Ala Ala Leu 20 25 30 Ala His Gly Lyβ Thr Val Leu Thr Asn Leu Leu Asp Ser Asp Asp Val 35 40 45 Arg His Met Leu Asn Ala Leu Thr Ala Leu Gl Val Ser Tyr Thr Leu 50 55 60 Ser Ala Asp Arg Thr Arg Cys Glu He He Gly Asn Gly Gly Pro Leu 65 70 75 80 His Ala Glu Gly Ala Leu Glu Leu Phe Leu Gly Asn Ala Gly Thr Ala 85 90 95 Met Arg Pro Leu Ala Ala Ala Leu Cyβ Leu Gly Ser Asn Asp He Val 100 105 110 Leu Thr Gly Glu Pro Arg Met Lys Glu Arg Pro He Gly His Leu Val 115 120 125 Asp Ala Leu Arg Leu Gly Gly Ala Lys He Thr Tyr Leu Glu Gin Glu 130 135 140 Asn Tyr Pro Pro Leu Arg Leu Gin Gly Gly Phe Thr Gly Gly Asn Val 145 150 155 160 Asp Val Asp Gly Ser Val Ser Ser Gin Phe Leu Thr Ala Leu Leu Met 165 170 175 Thr Ala Pro Leu Ala Pro Glu Asp Thr Val He Arg He Lys Gly Asp 180 185 190 Leu Val Ser Lye Pro Tyr He Asp He Thr Leu Asn Leu Met Lys Thr 195 200 205 Phe Gly Val Glu He Glu Asn Gin His Tyr Gin Gin Phe Val Val Lys 210 215 220 Gly Gly Gin Ser Tyr Gin Ser Pro Gly Thr Tyr Leu Val Glu Gly Asp 225 230 235 240 Ala Ser Ser Ala Ser Tyr Phe Leu Ala Ala Ala Ala He Lys Gly Gly 245 250 255 Thr Val Lyβ Val Thr Gly He Gly Arg Asn Ser Met Gin Gly Asp He 260 265 270 Arg Phe Ala Asp Val Leu Glu Lys Met Gly Ala Thr He Cys Trp Gly 275 280 285 Asp Asp Tyr He Ser Cys Thr Arg Gly Glu Leu Asn Ala He Asp Met 290 295 300 Asp Met Asn His He Pro Asp Ala Ala Met Thr He Ala Thr Ala Ala 305 310 315 320 Leu Phe Ala Lys Gly Thr Thr Arg Leu Arg Asn He Tyr Asn Trp Arg 325 330 335 Val Lys Glu Thr Asp Arg Leu Phe Ala Met Ala Thr Glu Leu Arg Lys 340 345 350 Val Gly Ala Glu Val Glu Glu Gly His Asp Tyr He Arg He Thr Pro 355 360 365 Pro Glu Lys Leu Asn Phe Ala Glu He Ala Thr Tyr Asn Asp Hie Arg 370 375 380 Met Ala Met Cyβ Phe Ser Leu Val Ala Leu Ser Aβp Thr Pro Val Thr 385 390 395 400 He Leu Asp Pro Lye Cyβ Thr Ala Lyβ Thr Phe Pro Aβp Tyr Phe Glu 405 410 415 Gln Leu Ala Arg He Ser Gin 420 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1377 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: CCATGGCTCA CGGTGCAAGC AGCCGTCCAG CAACTGCTCG TAAGTCCTCT GGTCTTTCTG 60 GAACCGTCCG TATTCCAGGT GACAAGTCTA TCTCCCACAG GTCCTTCATG TTTGGAGGTC 120 TCGCTAGCGG TGAAACTCGT ATCACCGGTC TTTTGGAAGG TGAAGATGTT ATCAACACTG 180 GTAAGGCTAT GCAAGCTATG GGTGCCAGAA TCCGTAAGGA AGGTGATACT TGGATCATTG 240 ATGGTGTTGG TAACGGTGGA CTCCTTGCTC CTGAGGCTCC TCTCGATTTC GGTAACGCTG 300 CAACTGGTTG CCGTTTGACT ATGGGTCTTG TTGGTGTTTA CGATTTCGAT AGCACTTTCA 360 TTGGTGACGC TTCTCTCACT AAGCGTCCAA TGGGTCGTGT GTTGAACCCA CTTCGCGAAA 420 TGGGTGTGCA GGTGAAGTCT GAAGACGGTG ATCGTCTTCC AGTTACCTTG CGTGGACCAA 480 AGACTCCAAC GCCAATCACC TACAGGGTAC CTATGGCTTC CGCTCAAGTG AAGTCCGCTG 540 TTCTGCTTGC TGGTCTCAAC ACCCCAGGTA TCACCACTGT TATCGAGCCA ATCATGACTC 600 GTGACCACAC TGAAAAGATG CTTCAAGGTT TTGGTGCTAA CCTTACCGTT GAGACTGATG 660 CTGACGGTGT GCGTACCATC CGTCTTGAAG GTCGTGGTAA GCTCACCGGT CAAGTGATTG 720 ATGTTCCAGG TGATCCATCC TCTACTGCTT TCCCATTGGT TGCTGCCTTG CTTGTTCCAG 780 GTTCCGACGT CACCATCCTT AACGTTTTGA TGAACCCAAC CCGTACTGGT CTCATCTTGA 840 CTCTGCAGGA AATGGGTGCC GACATCGAAG TGATCAACCC ACGTCTTGCT GGTGGAGAAG 900 ACGTGGCTGA CTTGCGTGTT CGTTCTTCTA CTTTGAAGGG TGTTACTGTT CCAGAAGACC 960 GTGCTCCTTC TATGATCGAC GAGTATCCAA TTCTCGCTGT TGCAGCTGCA TTCGCTGAAG 1020 GTGCTACCGT TATGAACGGT TTGGAAGAAC TCCGTGTTAA GGAAAGCGAC CGTCTTTCTG 1080 CTGTCGCAAA CGGTCTCAAG CTCAACGGTG TTGATTGCGA TGAAGGTGAG ACTTCTCTCG 1140 TCGTGCGTGG TCGTCCTGAC GGTAAGGGTC TCGGTAACGC TTCTGGAGCA GCTGTCGCTA 1200 CCCACCTCGA TCACCGTATC GCTATGAGCT TCCTCGTTAT GGGTCTCGTT TCTGAAAACC 1260 CTGTTACTGT TGATGATGCT ACTATGATCG CTACTAGCTT CCCAGAGTTC ATGGATTTGA 1320 TGGCTGGTCT TGGAGCTAAG ATCGAACTCT CCGACACTAA GGCTGCTTGA TGAGCTC 1377 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 318 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 87..317 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: AGATCTATCG ATAAGCTTGA TGTAATTGGA GGAAGATCAA AATTTTCAAT CCCCATTCTT 60 CGATTGCTTC AATTGAAGTT TCTCCG ATG GCG CAA GTT AGC AGA ATC TGC AAT 113 Met Ala Gin Val Ser Arg He Cys Asn 1 5 GGT GTG CAG AAC CCA TCT CTT ATC TCC AAT CTC TCG AAA TCC AGT CAA 161 Gly Val Gin Asn Pro Ser Leu He Ser Asn Leu Ser Lys Ser Ser Gin 10 15 20 25 CGC AAA TCT CCC TTA TCG GTT TCT CTG AAG ACG CAG CAG CAT CCA CGA 209 Arg Lys Ser Pro Leu Ser Val Ser Leu Lys Thr Gin Gin His Pro Arg 30 35 40 GCT TAT CCG ATT TCG TCG TCG TGG GGA TTG AAG AAG AGT GGG ATG ACG 257 Ala Tyr Pro He Ser Ser Ser Trp Gly Leu Lyβ Lyβ Ser Gly Met Thr 45 50 55 TTA ATT GGC TCT GAG CTT CGT CCT CTT AAG GTC ATG TCT TCT GTT TCC 305 Leu He Gly Ser Glu Leu Arg Pro Leu Lys Val Met Ser Ser Val Ser 60 65 70 ACG GCG TGC ATG C 318 75 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 77 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: Met Ala Gin Val Ser Arg He Cys Asn Gly Val Gin Asn Pro Ser Leu 1 5 10 15 He Ser Asn Leu Ser Lys Ser Ser Gin Arg Lys Ser Pro Leu Ser Val 20 25 30 Ser Leu Lys Thr Gin Gin His Pro Arg Ala Tyr Pro He Ser Ser Ser 35 40 45 Trp Gly Leu Lys Lys Ser Gly Met Thr Leu He Gly Ser Glu Leu Arg 50 55 60 Pro Leu Lyβ Val Met Ser Ser Val Ser Thr Ala Cys Met 65 70 75 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 402 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 87..401 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: AGATCTATCG ATAAGCTTGA TGTAATTGGA GGAAGATCAA AATTTTCAAT CCCCATTCTT 60 CGATTGCTTC AATTGAAGTT TCTCCG ATG GCG CAA GTT AGC AGA ATC TGC AAT 113 Met Ala Gin Val Ser Arg He Cys Asn 1 5 GGT GTG CAG AAC CCA TCT CTT ATC TCC AAT CTC TCG AAA TCC AGT CAA 161 Gly Val Gin Asn Pro Ser Leu He Ser Asn Leu Ser Lys Ser Ser Gin 10 15 20 25 CGC AAA TCT CCC TTA TCG GTT TCT CTG AAG ACG CAG CAG CAT CCA CGA 209 Arg Lys Ser Pro Leu Ser Val Ser Leu Lys Thr Gin Gin His Pro Arg 30 35 40 GCT TAT CCG ATT TCG TCG TCG TGG GGA TTG AAG AAG AGT GGG ATG ACG 257 Ala Tyr Pro He Ser Ser Ser Trp Gly Leu Lys Lyβ Ser Gly Met Thr 45 50 55 TTA ATT GGC TCT GAG CTT CGT CCT CTT AAG GTC ATG TCT TCT GTT TCC 305 Leu He Gly Ser Glu Leu Arg Pro Leu Lys Val Met Ser Ser Val Ser 60 65 70 ACG GCG GAG AAA GCG TCG GAG ATT GTA CTT CAA CCC ATT AGA GAA ATC 353 Thr Ala Glu Lys Ala Ser Glu He Val Leu Gin Pro He Arg Glu He 75 80 85 TCC GGT CTT ATT AAG TTG CCT GGC TCC AAG TCT CTA TCA AAT AGA ATT 401 Ser Gly Leu He Lys Leu Pro Gly Ser Lys Ser Leu Ser Asn Arg He 90 95 100 105 402 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 105 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: Met Ala Gin Val Ser Arg He Cys Asn Gly Val Gin Asn Pro Ser Leu 1 5 10 15 He Ser Asn Leu Ser Lys Ser Ser Gin Arg Lys Ser Pro Leu Ser Val 20 25 30 Ser Leu Lys Thr Gin Gin His Pro Arg Ala Tyr Pro He Ser Ser Ser 35 40 45 Trp Gly Leu Lys Lys Ser Gly Met Thr Leu He Gly Ser Glu Leu Arg 50 55 60 Pro Leu Lys Val Met Ser Ser Val Ser Thr Ala Glu Lyβ Ala Ser Glu 65 70 75 80 He Val Leu Gin Pro He Arg Glu He Ser Gly Leu He Lys Leu Pro 85 90 95 Gly Ser Lys Ser Leu Ser Asn Arg He 100 105 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 233 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) ( ix ) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 14..232 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: AGATCTTTCA AGA ATG GCA CAA ATT AAC AAC ATG GCT CAA GGG ATA CAA 49 Met Ala Gin He Asn Asn Met Ala Gin Gly He Gin 1 5 10 ACC CTT AAT CCC AAT TCC AAT TTC CAT AAA CCC CAA GTT CCT AAA TCT 97 Thr Leu Asn Pro Asn Ser Asn Phe His Lys Pro Gin Val Pro Lys Ser 15 20 25 TCA AGT TTT CTT GTT TTT GGA TCT AAA AAA CTG AAA AAT TCA GCA AAT 145 Ser Ser Phe Leu Val Phe Gly Ser Lys Lys Leu Lye Aβn Ser Ala Aβn 30 35 40 TCT ATG TTG GTT TTG AAA AAA GAT TCA ATT TTT ATG CAA AAG TTT TGT 193 Ser Met Leu Val Leu Lyβ Lys Asp Ser He Phe Met Gin Lys Phe Cys 45 50 55 60 TCC TTT AGG ATT TCA GCA TCA GTG GCT ACA GCC TGC ATG C 233 Ser Phe Arg He Ser Ala Ser Val Ala Thr Ala Cys Met 65 70 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 73 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: Met Ala Gin He Asn Asn Met Ala Gin Gly He Gin Thr Leu Asn Pro 1 5 10 15 Asn Ser Asn Phe His Lys Pro Gin Val Pro Lys Ser Ser Ser Phe Leu 20 25 30 Val Phe Gly Ser Lys Lys Leu Lys Asn Ser Ala Asn Ser Met Leu Val 35 40 45 Leu Lys Lys Asp Ser He Phe Met Gin Lys Phe Cyβ Ser Phe Arg He 50 55 60 Ser Ala Ser Val Ala Thr Ala Cyβ Met 65 70 (2) INFORMATION FOR SEQ ID NO:16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 352 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 49..351 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: AGATCTGCTA GAAATAATTT TGTTTAACTT TAAGAAGGAG ATATATCC ATG GCA CAA 57 Met Ala Gin 1 ATT AAC AAC ATG GCT CAA GGG ATA CAA ACC CTT AAT CCC AAT TCC AAT 105 He Asn Asn Met Ala Gin Gly He Gin Thr Leu Asn Pro Asn Ser Asn 5 10 15 TTC CAT AAA CCC CAA GTT CCT AAA TCT TCA AGT TTT CTT GTT TTT GGA 153 Phe His Lys Pro Gin Val Pro Lys Ser Ser Ser Phe Leu Val Phe Gly 20 25 30 35 TCT AAA AAA CTG AAA AAT TCA GCA AAT TCT ATG TTG GTT TTG AAA AAA 201 Ser Lys Lys Leu Lys Asn Ser Ala Asn Ser Met Leu Val Leu Lys Lys 40 45 50 GAT TCA ATT TTT ATG CAA AAG TTT TGT TCC TTT AGG ATT TCA GCA TCA 249 Asp Ser He Phe Met Gin Lys Phe Cys Ser Phe Arg He Ser Ala Ser 55 60 65 GTG GCT ACA GCA CAG AAG CCT TCT GAG ATA GTG TTG CAA CCC ATT AAA 297 Val Ala Thr Ala Gin Lys Pro Ser Glu He Val Leu Gin Pro He Lye 70 75 80 GAG ATT TCA GGC ACT GTT AAA TTG CCT GGC TCT AAA TCA TTA TCT AAT 345 Glu He Ser Gly Thr Val Lyβ Leu Pro Gly Ser Lyβ Ser Leu Ser Asn 85 90 95 AGA ATT C 352 Arg He 100 (2) INFORMATION FOR SEQ ID NO:17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 101 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: Met Ala Gin He Aβn Aβn Met Ala Gin Gly He Gin Thr Leu Aβn Pro 1 5 10 15 Asn Ser Asn Phe His Lys Pro Gin Val Pro Lys Ser Ser Ser Phe Leu 20 25 30 Val Phe Gly Ser Lyβ Lyβ Leu Lys Asn Ser Ala Asn Ser Met Leu Val 35 40 45 Leu Lys Lys Asp Ser He Phe Met Gin Lys Phe Cys Ser Phe Arg He 50 55 60 Ser Ala Ser Val Ala Thr Ala Gin Lys Pro Ser Glu He Val Leu Gin 65 70 75 80 Pro He Lys Glu He Ser Gly Thr Val Lys Leu Pro Gly Ser Lys Ser 85 90 95 Leu Ser Asn Arg He 100 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: Xaa His Gly Ala Ser Ser Arg Pro Ala Thr Ala Arg Lys Ser Ser Gly 1 5 10 15 Leu Xaa Gly Thr Val Arg He Pro Gly Asp Lys Met 20 25 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 13 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: Ala Pro Ser Met He Aβp Glu Tyr Pro He Leu Ala Val 1 5 10 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: He Thr Gly Leu Leu Glu Gly Glu Asp Val He Asn Thr Gly Lys 1 5 10 15 (2) INFORMATION FOR SEQ ID NO:21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: ATGATHGAYG ARTAYCC 17 (2) INFORMATION FOR SEQ ID NO:22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: GARGAYGTNA THAACAC 17 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: GARGAYGTNA THAATAC 17 (2) INFORMATION FOR SEQ ID NO:24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 38 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: CGTGGATAGA TCTAGGAAGA CAACCATGGC TCACGGTC 38 (2) INFORMATION FOR SEQ ID NO:25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 44 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: GGATAGATTA AGGAAGACGC GCATGCTTCA CGGTGCAAGC AGCC 44 (2) INFORMATION FOR SEQ ID NO:26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: GGCTGCCTGA TGAGCTCCAC AATCGCCATC GATGG 35 (2) INFORMATION FOR SEQ ID NO:27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 32 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: CGTCGCTCGT CGTGCGTGGC CGCCCTGACG GC 32 (2) INFORMATION FOR SEQ ID NO:28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: CGGGCAAGGC CATGCAGGCT ATGGGCGCC 29 (2) INFORMATION FOR SEQ ID NO:29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 31 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: CGGGCTGCCG CCTGACTATG GGCCTCGTCG G 31 (2) INFORMATION FOR SEQ ID NO:30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30: Xaa His Ser Ala Ser Pro Lys Pro Ala Thr Ala Arg Arg Ser Glu 1 5 10 15 (2) INFORMATION FOR SEQ ID NO:31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: GCGGTBGCSG GYTTSGG 17 (2) INFORMATION FOR SEQ ID NO:32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: Pro Gly Asp Lys Ser He Ser His Arg Ser Phe Met Phe Gly Gly Leu 1 5 10 15 (2) INFORMATION FOR SEQ ID NO:33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 13 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33: Leu Asp Phe Gly Asn Ala Ala Thr Gly Cys Arg Leu Thr 1 5 10 (2) INFORMATION FOR SEQ ID NO:34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:34: CGGCAATGCC GCCACCGGCG CGCGCC 26 (2) INFORMATION FOR SEQ ID NO:35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 49 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: GGACGGCTGC TTGCACCGTG AAGCATGCTT AAGCTTGGCG TAATCATGG 49 (2) INFORMATION FOR SEQ ID NO:36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) ( i) SEQUENCE DESCRIPTION: SEQ ID NO:36: GGAAGACGCC CAGAATTCAC GGTGCAAGCA GCCGG 35

Claims: Clairos: 1. An isolated DNA sequence encoding an EPSPS enzyme having a K m for phosphoenolpyruvate (PEP) between 1-150 μM and a Kj(glyphosate)/K m (PEP) ratio between 3-500, which DNA sequence is capable of hybridizing to a DNA probe from a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6. 2. A DNA molecule of claim 1 wherein said K m for phosphoenolpyruvate is between 2-25 μM. 3. A DNA molecule of claim 1 wherein said Kj/K m ratio is between 6-250. 4. An isolated DNA sequence encoding a protein which exhibits EPSPS activity wherein said protein is capable of reacting with antibodies raised against a Class II EPSPS enzyme. 5. The DNA sequence of Claim 4 wherein said protein is capable of reacting with antibodies raised against a Class II EPSPS enzyme selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, and SEQ ID NO:7. 6. The DNA sequence of Claim 5 wherein said antibodies are raised against a Class II EPSPS enzyme of SEQ ID NO:3. 7. A recombinant, double-stranded DNA molecule comprising in sequence: a) a promoter which functions in plant cells to cause the production of an RNA sequence; b) a structural DNA sequence that causes the production of an RNA sequence which encodes a Class II EPSPS enzyme; and c) a 3' non-translated region which functions in plant cells to cause the addition of a stretch of polyadenyl nucleotides to the 3' end of the RNA sequence where the promoter is heterologous with respect to the structural DNA sequence and adapted to cause sufficient expression of the fusion polypeptide to enhance the glyphosate tolerance of a plant cell transformed with said DNA molecule. 8. The DNA molecule of Claim 7 in which said structural DNA sequence encodes a fusion polypeptide comprising an amino-terminal chloroplast transit peptide and a Class II EPSPS enzyme. 9. The DNA molecule of Claim 8 wherein said structural DNA sequence encoding a Class II EPSPS enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6. 10. The DNA molecule of Claim 9 wherein said sequence is from SEQ ID NO:2. 11. A DNA molecule of Claim 8 in which the promoter is a plant DNA virus promoter. 12. A DNA molecule of Claim 11 in which the promoter is selected from the group consisting of CaMV35S and FMV35S promoters. 13. A method of producing genetically transformed plants which are tolerant toward glyphosate herbicide, comprising the steps of: a) inserting into the genome of a plant cell a recombinant, double- stranded DNA molecule comprising: i) a promoter which functions in plant cells to cause the production of an RNA sequence, ii) a structural DNA sequence that causes the production of an RNA sequence which encodes a fusion polypeptide comprising an amino terminal chloroplast transit peptide and a Class II EPSPS enzyme, iii) a 3' non-translated DNA sequence which functions in plant cells to cause the addition of a stretch of polyadenyl nucleotides to the 3' end of the RNA sequence where the promoter is heterologous with respect to the structural DNA sequence and adapted to cause sufficient expression of the fusion polypeptide to enhance the glyphosate tolerance of a plant cell transformed with said gene; b) obtaining a transformed plant cell; and c) regenerating from the transformed plant cell a genetically transformed plant which has increased tolerance to glyphosate herbicide. 14. The method of Claim 13 wherein said structural DNA sequence encoding a Class II EPSPS enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6. 15. The DNA molecule of Claim 14 wherein said sequence is that as set forth in SEQ ID NO:2. 16. A method of Claim 13 in which the promoter is from a plant DNA virus. 17. A method of Claim 16 in which the promoter is selected from the group consisting of CaMV35S and FMV35S promoters. 18. A glyphosate tolerant plant cell comprising a DNA molecule of Claims 8, 9 or 12. 19. A glyphosate tolerant plant cell of Claim 18 in which the promoter is a plant DNA virus promoter. 20. A glyphosate tolerant plant cell of Claim 19 in which the promoter is selected from the group consisting of CaMV35S and FMV35S promoters. 21. A glyphosate tolerant plant cell of Claim 18 selected from the group consisting of corn, wheat, rice, soybean, cotton, sugarbeet, oilseed rape, canola, flax, sunflower, potato, tobacco, tomato, alfalfa, poplar, pine, apple and grape. 22. A glyphosate tolerant plant comprising plant cells of Claim 18. 23. A glyphosate tolerant plant of Claim 22 in which the promoter is from a DNA plant virus promoter. 24. A glyphosate tolerant plant of Claim 23 in which the promoter is selected from the group consisting of CaMV35S and FMV35S promoters. 25. A glyphosate tolerant plant of Claim 22 selected from the group consisting of corn, wheat, rice, soybean, cotton, sugarbeet, oilseed rape, canola, flax, sunflower, potato, tobacco, tomato, alfalfa, poplar, pine, apple and grape. 26. A method for selectively controlling weeds in a field containing a crop having planted crop seeds or plants comprising the steps of: a) planting said crop seeds or plants which are glyphosate tolerant as a result of a recombinant double- stranded DNA molecule being inserted into said crop seed or plant, said DNA molecule having: i) a promoter which functions in plant cells to cause the production of an RNA sequence, ii) a structural DNA sequence that causes the production of an RNA sequence which encodes a polypeptide which comprises an amino terminal chloroplast transit peptide and a Class II EPSPS enzyme, iii) a 3' non-translated DNA sequence which functions in plant cells to cause the addition of a stretch of polyadenyl nucleotides to the 3' end of the RNA sequence where the promoter is heterologous with respect to the structural DNA sequence and adapted to cause sufficient expression of the fusion polypeptide to enhance the glyphosate tolerance of a plant cell transformed with said gene; and b) applying to said crop and weeds in said field a sufficient amount of glyphosate herbicide to control said weeds without significantly affecting said crop. 27. The method of Claim 26 wherein said structural DNA sequence encoding a Class II EPSPS enzyme is selected from the sequences as set forth in SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6. 28. A method of Claim 27 in which said DNA molecule contains a structural DNA sequence from SEQ ID NO:2. 29. A method of Claim 28 in which said DNA molecule further comprises a promoter selected from the group consisting of the CAMV35SS and FMV35S promoters. 30. A method of Claim 29 in which the crop plant is selected from the group consisting of corn, wheat, rice, soybean, cotton, sugarbeet, oilseed rape, canola, flax, sunflower, potato, tobacco, tomato, alfalfa, poplar, pine, apple and grape.

Inventors: BARRY GERARD FRANCIS, KISHORE GANESH MURTHY, PADGETTE STEPHEN ROGERS, BARRY, GERARD, FRANCIS, KISHORE, GANESH, MURTHY, PADGETTE, STEPHEN, ROGERS
Applicants: MONSANTO CO, MONSANTO COMPANY
Application year: 1991
Main classification: A01H5
IPC codes: A01H5, C12N5, C12N9, C12N15, C12Q1, C12R1